false10-312025Q20000810136P6MP3DP30DP1MP14DP21DP7DP14DP2MP1YP1YP1Y201900008101362024-11-012025-05-0400008101362025-06-0500008101362025-05-0400008101362024-10-3100008101362024-01-292024-04-2800008101362023-11-012024-04-2800008101362025-02-032025-05-040000810136us-gaap:CommonStockMember2025-02-0200008101362023-10-310000810136us-gaap:AdditionalPaidInCapitalMember2023-10-310000810136us-gaap:RetainedEarningsMember2024-01-280000810136us-gaap:NoncontrollingInterestMember2024-01-280000810136us-gaap:RetainedEarningsMember2023-10-310000810136us-gaap:NoncontrollingInterestMember2023-10-310000810136us-gaap:CommonStockMember2023-10-310000810136us-gaap:RetainedEarningsMember2025-02-020000810136us-gaap:AdditionalPaidInCapitalMember2024-01-280000810136us-gaap:CommonStockMember2024-10-3100008101362025-02-020000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-02-020000810136us-gaap:CommonStockMember2024-01-280000810136us-gaap:RetainedEarningsMember2024-10-310000810136us-gaap:NoncontrollingInterestMember2025-02-020000810136us-gaap:NoncontrollingInterestMember2024-10-310000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-2800008101362024-01-280000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-310000810136us-gaap:AdditionalPaidInCapitalMember2024-10-310000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-310000810136us-gaap:AdditionalPaidInCapitalMember2025-02-020000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-02-032025-05-040000810136us-gaap:CommonStockMember2024-01-292024-04-280000810136us-gaap:CommonStockMember2024-11-012025-05-040000810136us-gaap:RetainedEarningsMember2023-11-012024-04-280000810136us-gaap:CommonStockMember2025-02-032025-05-040000810136us-gaap:NoncontrollingInterestMember2025-02-032025-05-040000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-11-012025-05-040000810136us-gaap:AdditionalPaidInCapitalMember2024-01-292024-04-280000810136us-gaap:NoncontrollingInterestMember2023-11-012024-04-280000810136us-gaap:RetainedEarningsMember2025-02-032025-05-040000810136us-gaap:RetainedEarningsMember2024-11-012025-05-040000810136us-gaap:AdditionalPaidInCapitalMember2024-11-012025-05-040000810136us-gaap:AdditionalPaidInCapitalMember2023-11-012024-04-280000810136us-gaap:CommonStockMember2023-11-012024-04-280000810136us-gaap:NoncontrollingInterestMember2024-11-012025-05-040000810136us-gaap:RetainedEarningsMember2024-01-292024-04-280000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-292024-04-280000810136us-gaap:AdditionalPaidInCapitalMember2025-02-032025-05-040000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-11-012024-04-280000810136us-gaap:NoncontrollingInterestMember2024-01-292024-04-280000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-280000810136us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-05-040000810136us-gaap:NoncontrollingInterestMember2024-04-280000810136us-gaap:NoncontrollingInterestMember2025-05-040000810136us-gaap:CommonStockMember2024-04-280000810136us-gaap:AdditionalPaidInCapitalMember2025-05-040000810136us-gaap:CommonStockMember2025-05-040000810136us-gaap:RetainedEarningsMember2025-05-040000810136us-gaap:RetainedEarningsMember2024-04-280000810136us-gaap:AdditionalPaidInCapitalMember2024-04-2800008101362024-04-280000810136us-gaap:EmployeeStockOptionMember2024-11-012025-05-040000810136us-gaap:RestrictedStockMember2024-11-012025-05-040000810136us-gaap:RestrictedStockUnitsRSUMember2024-11-012025-05-040000810136country:KR2024-11-012025-05-040000810136srt:EuropeMember2024-11-012025-05-040000810136country:CN2024-11-012025-05-040000810136country:TW2024-11-012025-05-040000810136country:US2024-11-012025-05-040000810136us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2024-10-310000810136us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2024-10-310000810136us-gaap:FairValueInputsLevel2Memberus-gaap:BankTimeDepositsMember2025-05-040000810136us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2024-10-310000810136us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialPaperMember2025-05-040000810136us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMember2025-05-040000810136us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2025-05-040000810136us-gaap:CashMember2025-05-040000810136us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2024-10-310000810136us-gaap:CashMember2024-10-310000810136us-gaap:BuildingAndBuildingImprovementsMember2024-10-310000810136us-gaap:MachineryAndEquipmentMember2025-05-040000810136us-gaap:FurnitureAndFixturesMember2025-05-040000810136us-gaap:LeaseholdImprovementsMember2025-05-040000810136us-gaap:ConstructionInProgressMember2024-10-310000810136us-gaap:BuildingAndBuildingImprovementsMember2025-05-040000810136us-gaap:FurnitureAndFixturesMember2024-10-310000810136us-gaap:LandMember2024-10-310000810136us-gaap:LandMember2025-05-040000810136us-gaap:MachineryAndEquipmentMember2024-10-310000810136us-gaap:ConstructionInProgressMember2025-05-040000810136us-gaap:LeaseholdImprovementsMember2024-10-310000810136us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-11-012025-05-040000810136us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2018-01-012018-01-310000810136plab:PhotronicsAndDNPMembersrt:MinimumMember2024-11-012025-05-040000810136plab:PhotronicsAndDNPMember2024-11-012025-05-040000810136plab:PhotronicsAndDNPMember2023-11-012024-04-280000810136plab:PhotronicsAndDNPMember2025-02-032025-05-040000810136plab:PhotronicsAndDNPMember2024-01-292024-04-280000810136plab:PDMCXMember2024-10-310000810136us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2025-05-040000810136plab:PDMCXMember2025-05-040000810136us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-10-310000810136plab:FinanceLeaseMember2025-05-040000810136plab:FinanceLeaseMember2024-10-310000810136plab:FinanceLeaseMember2024-11-012025-05-040000810136plab:FinanceLeaseMember2023-11-012024-10-310000810136plab:Seven2MillionFinanceLeaseMember2025-05-040000810136plab:Three55MillionFinanceLeaseMember2025-05-040000810136plab:Seven2MillionFinanceLeaseMember2021-02-280000810136plab:Three55MillionFinanceLeaseMember2020-12-310000810136plab:MonthlyMemberplab:Seven2MillionFinanceLeaseMember2021-02-012021-02-280000810136plab:FollowingNineMonthsMemberplab:Three55MillionFinanceLeaseMember2021-01-012021-01-310000810136plab:FirstThreeMonthsMemberplab:Three55MillionFinanceLeaseMember2021-01-012021-01-310000810136plab:FollowedByThirtySixMonthsMemberplab:Three55MillionFinanceLeaseMember2021-01-012021-01-310000810136plab:Three55MillionFinanceLeaseMember2021-01-310000810136plab:WorkingCapitalLoanMember2018-11-300000810136plab:WorkingCapitalLoanMember2024-08-310000810136plab:WorkingCapitalLoanMember2022-12-012022-12-310000810136plab:WorkingCapitalLoanMember2024-11-012025-05-040000810136plab:WorkingCapitalLoanMember2025-05-040000810136us-gaap:OtherCurrentAssetsMember2025-05-040000810136us-gaap:OtherCurrentAssetsMember2024-10-310000810136us-gaap:OtherNoncurrentLiabilitiesMember2025-05-040000810136us-gaap:OtherNoncurrentLiabilitiesMember2024-10-310000810136plab:AccruedLiabilitiesCurrentMember2024-10-310000810136plab:AccruedLiabilitiesCurrentMember2025-05-040000810136srt:MinimumMember2024-11-012025-05-040000810136srt:MaximumMember2024-11-012025-05-040000810136plab:IntegratedCircuitsMembersrt:MaximumMember2024-11-012025-05-040000810136plab:FlatPanelDisplaysMembersrt:MaximumMember2024-11-012025-05-040000810136srt:MinimumMemberplab:IntegratedCircuitsMember2024-11-012025-05-040000810136srt:MinimumMemberplab:FlatPanelDisplaysMember2024-11-012025-05-040000810136country:TW2024-01-292024-04-280000810136country:CN2025-02-032025-05-040000810136plab:OtherMember2023-11-012024-04-280000810136srt:EuropeMember2025-02-032025-05-040000810136plab:MainstreamIntegratedCircuitsMember2025-02-032025-05-040000810136country:TW2025-02-032025-05-040000810136country:CN2024-01-292024-04-280000810136plab:HighEndFlatPanelDisplaysMember2024-11-012025-05-040000810136country:US2023-11-012024-04-280000810136us-gaap:TransferredOverTimeMember2025-02-032025-05-040000810136plab:FlatPanelDisplaysMember2024-01-292024-04-280000810136plab:HighEndIntegratedCircuitsMember2024-01-292024-04-280000810136plab:HighEndFlatPanelDisplaysMember2025-02-032025-05-040000810136plab:OtherMember2024-11-012025-05-040000810136plab:HighEndIntegratedCircuitsMember2024-11-012025-05-040000810136plab:MainstreamIntegratedCircuitsMember2024-01-292024-04-280000810136plab:OtherMember2025-02-032025-05-040000810136srt:EuropeMember2024-01-292024-04-280000810136plab:IntegratedCircuitsMember2025-02-032025-05-040000810136plab:MainstreamFlatPanelDisplaysMember2023-11-012024-04-280000810136country:CN2023-11-012024-04-280000810136country:KR2024-01-292024-04-280000810136us-gaap:TransferredAtPointInTimeMember2024-11-012025-05-040000810136us-gaap:TransferredOverTimeMember2023-11-012024-04-280000810136plab:HighEndFlatPanelDisplaysMember2023-11-012024-04-280000810136plab:MainstreamFlatPanelDisplaysMember2024-11-012025-05-040000810136us-gaap:TransferredAtPointInTimeMember2024-01-292024-04-280000810136country:KR2025-02-032025-05-040000810136us-gaap:TransferredAtPointInTimeMember2025-02-032025-05-040000810136plab:FlatPanelDisplaysMember2025-02-032025-05-040000810136us-gaap:TransferredOverTimeMember2024-01-292024-04-280000810136plab:IntegratedCircuitsMember2024-01-292024-04-280000810136plab:MainstreamFlatPanelDisplaysMember2025-02-032025-05-040000810136plab:HighEndIntegratedCircuitsMember2025-02-032025-05-040000810136plab:HighEndIntegratedCircuitsMember2023-11-012024-04-280000810136plab:MainstreamFlatPanelDisplaysMember2024-01-292024-04-280000810136us-gaap:TransferredOverTimeMember2024-11-012025-05-040000810136plab:FlatPanelDisplaysMember2023-11-012024-04-280000810136country:TW2023-11-012024-04-280000810136plab:FlatPanelDisplaysMember2024-11-012025-05-040000810136us-gaap:TransferredAtPointInTimeMember2023-11-012024-04-280000810136plab:MainstreamIntegratedCircuitsMember2024-11-012025-05-040000810136plab:MainstreamIntegratedCircuitsMember2023-11-012024-04-280000810136plab:IntegratedCircuitsMember2024-11-012025-05-040000810136country:KR2023-11-012024-04-280000810136country:US2025-02-032025-05-040000810136srt:EuropeMember2023-11-012024-04-280000810136plab:HighEndFlatPanelDisplaysMember2024-01-292024-04-280000810136plab:IntegratedCircuitsMember2023-11-012024-04-280000810136country:US2024-01-292024-04-280000810136plab:OtherMember2024-01-292024-04-280000810136plab:Two025EquityIncentiveCompensationPlanMember2025-04-020000810136us-gaap:CostOfSalesMember2024-11-012025-05-040000810136us-gaap:ResearchAndDevelopmentExpenseMember2024-01-292024-04-280000810136us-gaap:RestrictedStockUnitsRSUMember2025-02-032025-05-040000810136us-gaap:ResearchAndDevelopmentExpenseMember2024-11-012025-05-040000810136us-gaap:EmployeeStockMember2024-01-292024-04-280000810136us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-02-032025-05-040000810136us-gaap:CostOfSalesMember2025-02-032025-05-040000810136us-gaap:RestrictedStockUnitsRSUMember2023-11-012024-04-280000810136us-gaap:RestrictedStockMember2023-11-012024-04-280000810136us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-11-012025-05-040000810136us-gaap:EmployeeStockMember2023-11-012024-04-280000810136us-gaap:EmployeeStockMember2024-11-012025-05-040000810136us-gaap:EmployeeStockMember2025-02-032025-05-040000810136us-gaap:ResearchAndDevelopmentExpenseMember2025-02-032025-05-040000810136us-gaap:CostOfSalesMember2024-01-292024-04-280000810136us-gaap:RestrictedStockMember2025-02-032025-05-040000810136us-gaap:RestrictedStockUnitsRSUMember2024-01-292024-04-280000810136us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-11-012024-04-280000810136us-gaap:ResearchAndDevelopmentExpenseMember2023-11-012024-04-280000810136us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-292024-04-280000810136us-gaap:RestrictedStockMember2024-01-292024-04-280000810136us-gaap:CostOfSalesMember2023-11-012024-04-280000810136srt:MaximumMemberus-gaap:RestrictedStockMember2024-11-012025-05-040000810136srt:MaximumMemberus-gaap:EmployeeStockOptionMember2024-11-012025-05-040000810136us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2024-11-012025-05-040000810136us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2024-11-012025-05-040000810136srt:MinimumMemberus-gaap:RestrictedStockMember2024-11-012025-05-040000810136srt:MinimumMemberus-gaap:EmployeeStockOptionMember2024-11-012025-05-040000810136us-gaap:RestrictedStockMember2025-05-040000810136us-gaap:RestrictedStockUnitsRSUMember2024-04-280000810136us-gaap:RestrictedStockUnitsRSUMember2025-05-040000810136us-gaap:RestrictedStockMember2024-04-280000810136us-gaap:EmployeeStockOptionMember2024-01-292024-04-280000810136us-gaap:EmployeeStockOptionMember2025-02-032025-05-040000810136us-gaap:EmployeeStockOptionMember2023-11-012024-04-280000810136us-gaap:EmployeeStockOptionMember2024-04-280000810136us-gaap:EmployeeStockOptionMember2025-05-040000810136us-gaap:StockCompensationPlanMember2024-01-292024-04-280000810136us-gaap:StockCompensationPlanMember2024-11-012025-05-040000810136us-gaap:StockCompensationPlanMember2025-02-032025-05-040000810136us-gaap:StockCompensationPlanMember2023-11-012024-04-280000810136plab:AccumulatedOtherComprehensiveIncomeOtherMember2024-10-310000810136plab:AccumulatedOtherComprehensiveIncomeOtherMember2024-01-280000810136us-gaap:AccumulatedTranslationAdjustmentMember2025-02-020000810136us-gaap:AccumulatedTranslationAdjustmentMember2024-10-310000810136plab:AccumulatedOtherComprehensiveIncomeOtherMember2023-10-310000810136plab:AccumulatedOtherComprehensiveIncomeOtherMember2025-02-020000810136us-gaap:AccumulatedTranslationAdjustmentMember2023-10-310000810136us-gaap:AccumulatedTranslationAdjustmentMember2024-01-280000810136us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-292024-04-280000810136us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-01-292024-04-280000810136plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember2024-11-012025-05-040000810136plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember2023-11-012024-04-280000810136us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2025-02-032025-05-040000810136us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-11-012025-05-040000810136us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-11-012024-04-280000810136plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember2024-01-292024-04-280000810136us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2023-11-012024-04-280000810136plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember2025-02-032025-05-040000810136us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2024-11-012025-05-040000810136us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2025-02-032025-05-040000810136plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember2024-01-292024-04-280000810136plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember2025-02-032025-05-040000810136us-gaap:AociAttributableToNoncontrollingInterestMember2024-11-012025-05-040000810136us-gaap:AociAttributableToNoncontrollingInterestMember2023-11-012024-04-280000810136us-gaap:AociAttributableToNoncontrollingInterestMember2025-02-032025-05-040000810136plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember2023-11-012024-04-280000810136us-gaap:AociAttributableToNoncontrollingInterestMember2024-01-292024-04-280000810136us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2024-11-012025-05-040000810136us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2023-11-012024-04-280000810136plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember2024-11-012025-05-040000810136us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2025-02-032025-05-040000810136us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember2024-01-292024-04-280000810136us-gaap:AccumulatedTranslationAdjustmentMember2025-05-040000810136us-gaap:AccumulatedTranslationAdjustmentMember2024-04-280000810136plab:AccumulatedOtherComprehensiveIncomeOtherMember2025-05-040000810136plab:AccumulatedOtherComprehensiveIncomeOtherMember2024-04-280000810136plab:September2020AnnouncedProgramMember2020-09-300000810136plab:ShareRepurchaseProgramsMember2024-08-310000810136plab:ShareRepurchaseProgramsMember2020-09-162022-10-310000810136plab:ShareRepurchaseProgramsMember2024-01-292024-04-280000810136plab:ShareRepurchaseProgramsMember2025-02-032025-05-040000810136plab:ShareRepurchaseProgramsMember2023-11-012024-04-280000810136plab:ShareRepurchaseProgramsMember2024-11-012025-05-040000810136plab:ShareRepurchaseProgramsMember2024-07-310000810136plab:September2020AnnouncedProgramMember2025-05-04xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesplab:Facilityxbrli:pureiso4217:CNY

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, ~~D.C.~~DC 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~May~~August 43, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission file number 0-15451

PHOTRONICS, INC.

(Exact name of registrant as specified in its charter)

Connecticut		06-0854886
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

15 Secor Road, Brookfield, Connecticut		06804
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code

(203) 775-9000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered COMMON STOCK PLAB NASDAQ Global Select Market

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
COMMON STOCK $0.01 par value	PLAB	NASDAQ Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

Large Accelerated Filer	Accelerated Filer	Non-Accelerated Filer	Smaller Reporting Company	Emerging Growth Company
☒	☐	☐	☐	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

The registrant had 6059,~~150~~004,~~512~~625 shares of common stock outstanding as of ~~June~~September 54, 2025.

PHOTRONICS, INC.

QUARTERLY REPORT ON FORM 10-Q

~~May~~August 43, 2025

TABLE OF CONTENTS

Glossary of Terms and Acronyms		3	3
Forward-Looking Statements		4	4
PART I.	~~FINANCIAL INFORMATION~~	FINANCIAL INFORMATION
Item 1.	~~Financial Statements (unaudited)~~	5Financial Statements (unaudited)	5
	~~Condensed Consolidated Balance Sheets~~	5Condensed Consolidated Balance Sheets	5
	~~Condensed Consolidated Statements of Income~~	6Condensed Consolidated Statements of Income	6
	~~Condensed Consolidated Statements of Comprehensive Income~~	7Condensed Consolidated Statements of Comprehensive Income	7
	~~Condensed Consolidated Statements of Equity~~	8Condensed Consolidated Statements of Equity	8
	~~Condensed Consolidated Statements of Cash Flows~~	10Condensed Consolidated Statements of Cash Flows	10
	~~Notes to Condensed Consolidated Financial Statements~~	11Notes to Condensed Consolidated Financial Statements	11
Item 2.	~~Management’s Discussion and Analysis of Financial Condition and Results of Operations~~	26Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	~~Quantitative and Qualitative Disclosures about Market Risk~~	33Quantitative and Qualitative Disclosures about Market Risk	33
Item 4.	~~Controls and Procedures~~	33Controls and Procedures	34
PART II.	~~OTHER INFORMATION~~	OTHER INFORMATION
Item 1.	~~Legal Proceedings~~	34Legal Proceedings	35
Item 1A.	~~Risk Factors~~	34Risk Factors	35
Item 2.	~~Unregistered Sales of Equity Securities and Use of Proceeds~~	34Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3.	~~Defaults Upon Senior Securities~~	35Defaults Upon Senior Securities	36
Item 4.	~~Mine Safety Disclosures~~	35Mine Safety Disclosures	36
Item 5.	~~Other Information~~	35Other Information	36
Item 6.	~~Exhibits~~	36Exhibits	37

Table of Contents

Glossary of Terms and Acronyms

Definitions of certain terms and acronyms that may appear in this report are provided below.

~~AMOLED~~	~~Active-matrix organic light-emitting diode. A technology used in mobile devices.~~AMOLED	Active-matrix organic light-emitting diode. A technology used in mobile devices.
~~ASC~~	~~Accounting Standards Codification~~ASC	Accounting Standards Codification
~~ASP~~	~~Average Selling Price~~ASP	Average Selling Price
~~ASU~~	~~Accounting Standards Update~~ASU	Accounting Standards Update
~~CNY~~	~~Chinese Yuan~~CNY	Chinese Yuan
~~DNP~~	~~Dai Nippon Printing Co., Ltd.~~DNP	Dai Nippon Printing Co., Ltd.
~~Exchange Act~~	~~The Securities~~ Exchange Act ~~of 1934 (as amended)~~	The Securities Exchange Act of 1934 (as amended)
~~Form 10-K~~	~~Annual Report on~~ Form 10-K	Annual Report on Form 10-K
~~Form 10-Q~~	~~Quarterly Report on~~ Form 10-Q	Quarterly Report on Form 10-Q
~~FPD~~	~~Flat Panel Display~~FPD	Flat Panel Display
FY	~~Fiscal Year~~FY	Fiscal Year
~~Generation~~	~~In reference to flat panel displays, refers to the size range of the underlying substrate to which a photomask is applied. Higher generation (or “G”) numbers represent larger substrates~~Generation	In reference to flat panel displays, it refers to the size range of the underlying substrate to which a photomask is applied. Higher generation (or “G”) numbers represent larger substrates
~~High-end (photomasks)~~	~~For~~High-end ~~IC,~~ (photomasks ~~that service IC nodes at 28nm or smaller; for FPD, AMOLED, G10.5+, and LTPS photomasks~~)	For IC, photomasks that service IC nodes at 28nm or smaller; for FPD, AMOLED, G10.5+, and LTPS photomasks
IC	~~Integrated circuit~~IC	Integrated circuit
~~LTPS~~	Low-Temperature Poly Silicon, a polycrystalline silicon synthesized at relatively low temperatures; polycrystalline silicon in thin-film transistors (TFTs) are used in liquid-crystal display (LCD) flat panels and to drive organic light-emitting diode (OLED) displaysLTPS	Low-Temperature Poly Silicon, a polycrystalline silicon synthesized at relatively low temperatures; polycrystalline silicon in thin-film transistors (TFTs) are used in liquid-crystal display (LCD) flat panels and to drive organic light-emitting diode (OLED) displays
~~Mainstream (photomasks)~~	~~For~~Mainstream ~~IC,~~ (photomasks ~~that service IC nodes greater than 28nm; for FPD, G8 and smaller photomasks~~)	For IC, photomasks that service IC nodes greater than 28nm; for FPD, G8 and smaller photomasks
~~PDMCX~~	~~Xiamen American Japan Photronics Mask Co., Ltd., a joint venture of Photronics and DNP~~PDMCX	Xiamen American Japan Photronics Mask Co., Ltd., a joint venture of Photronics and DNP
~~ROU (assets)~~	~~Right-of-use~~ROU ~~asset~~(assets)	Right-of-use asset
~~SEC~~	~~Securities and Exchange Commission~~SEC	Securities and Exchange Commission
~~U.S. GAAP~~	~~Accounting~~U.S. ~~principles generally accepted in the United States of America~~GAAP	Accounting principles generally accepted in the United States of America
~~VIE~~	~~Variable Interest Entity~~VIE	Variable Interest Entity
~~Wafer~~	~~A wafer, or silicon wafer, is a thin slice of semiconductor material that, in the fabrication of microelectronics, serves as the substrate for microelectronic devices built in and upon the wafer~~Wafer	A wafer, or silicon wafer, is a thin slice of semiconductor material that, in the fabrication of microelectronics, serves as the substrate for microelectronic devices built in and upon the wafer

Table of Contents

Forward-Looking Statements

This Form 10-Q contains forward-looking statements, as defined by the SEC. The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements made by us, or on our behalf. Forward-looking statements are statements other than statements of historical fact, including, without limitation, those statements that include such words as “anticipates”, “believes”, “estimates”, “expects”, “intends”, “may”, “plans”, “predicts”, and similar expressions, and, without limitation, may address our future plans, objectives, goals, strategies, events, or performance, as well as underlying assumptions and other statements that are other than statements of historical facts. On occasion, in other documents filed with the SEC, press releases, conferences, or by other means, we may discuss, publish, disseminate, or otherwise make available, forward-looking statements, including statements contained within Part I, Item 2 – “Management’s Discussion & Analysis of Financial Condition and Results of Operations” of this Form 10-Q.

Forward-looking statements involve risks and uncertainties, which could cause actual results or outcomes to differ materially from those expressed. Our expectations, beliefs, and projections are expressed in good faith and are believed by us to have a reasonable basis, including, without limitation, management’s examination of historical operating trends, information contained in our records, and information we~~’ve~~ have obtained from other parties. However, we can offer no assurance that our expectations, beliefs, or projections will be realized, accomplished, or achieved.

Forward-looking statements within this Form 10-Q speak only as of the date of its filing, and we undertake no obligation to update any such statements to reflect changes in events or circumstances that may subsequently occur. Users of this Form 10-Q are cautioned that various factors may cause actual results to differ materially from those contained in any forward-looking statements found within this Form 10-Q and that they should not place undue reliance on any forward-looking statement. In addition, all forward-looking statements, whether written or oral and whether made by us or on our behalf, are expressly qualified by the risk factors provided in Part I, Item 1A “Risk Factors” contained in Form 10-K for the year ended October 31, 2024, filed with the SEC on December 19, 2024, as well as any additional risk factors we may provide in Part II, Item 1A in this Quarterly Report on Form 10-Q.

Table of Contents

PART I.

FINANCIAL INFORMATION

Item 1.

FINANCIAL STATEMENTS

PHOTRONICS, INC.

Condensed Consolidated Balance Sheets

(in thousands, except per share amounts)

(unaudited)

	May 4, 2025			October 31, 2024
	August 3,			October 31,
	2025			2024
ASSETS
Current assets:
Cash and cash equivalents	$	~~530~~479,~~708~~521		$	598,485
Short-term investments		2796,~~699~~277			42,184
Accounts receivable, net of allowance of $1,171 in 2025 and $1,126 in 2024		195,977			200,830
Accounts receivable, net of allowance of $1,184 in 2025 and $1,126 in 2024		190,875			200,830
Inventories		6163,~~201~~490			56,527
Other current assets		4042,~~221~~073			33,036
Total current assets		~~855~~872,~~806~~236			931,062
Property, plant and equipment, net		~~807~~838,~~558~~988			745,257
Deferred income taxes		2426,~~727~~419			23,059
Other assets		1415,~~941~~122			12,681
Total assets	$	1,~~703~~752,~~032~~765		$	1,712,059
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt	$	11		$	17,972
Accounts payable		89100,~~484~~351			78,717
Accrued liabilities		7774,~~288~~563			87,122
Total current liabilities		~~166~~174,~~783~~925			183,811
Long-term debt		1916			25
Other liabilities		39,~~461~~824			47,464
Total liabilities		~~206~~214,~~263~~765			231,300
Commitments and contingencies (Note 12)
Equity:
Preferred stock, $0.01 par value, 2,000 shares authorized, none issued and outstanding		-			-
Common stock, $0.01 par value, 150,000 shares authorized, 58,711 shares issued and outstanding as of May 4, 2025, and 61,949 shares issued and outstanding as of October 31, 2024		587			619
Common stock, $0.01 par value, 150,000 shares authorized, 57,587 shares issued and outstanding as of August 3, 2025, and 61,949 shares issued and outstanding as of October 31, 2024		576			619
Additional paid-in capital		~~489~~483,~~205~~081			514,757
Retained earnings		~~698~~710,~~423~~398			691,807
Accumulated other comprehensive loss		(8768,~~295~~504	)		(86,319	)
Total Photronics, Inc. shareholders’ equity		1,~~100~~125,~~920~~551			1,120,864
Noncontrolling interests		~~395~~412,~~849~~449			359,895
Total equity		1,~~496~~538,~~769~~000			1,480,759
Total liabilities and equity	$	1,~~703~~752,~~032~~765		$	1,712,059

See accompanying notes to condensed consolidated financial statements.

Table of Contents

PHOTRONICS, INC.

Condensed Consolidated Statements of Income

(in thousands, except per share amounts)

(unaudited)

	Three Months Ended						~~Six~~Nine Months Ended
	May 4, 2025			April 28, 2024			May 4, 2025			April 28, 2024
	August 3,			July 28,			August 3,			July 28,
Revenue	$	210,992		$	217,000		$	423,130		$	433,334
	2025			2024			2025			2024
Cost of goods sold		133,086			137,749			269,689			274,828
Revenue	$	210,394		$	210,984		$	633,524		$	644,318
Gross profit		77,906			79,251			153,441			158,506
Cost of goods sold		139,539			135,846			409,228			410,674
Gross profit		70,855			75,138			224,296			233,644
Operating expenses:
Selling, general, and administrative		18,~~099~~423			1819,~~996~~436			3755,~~201~~624			3756,~~317~~753
Research and development		4,~~090~~271			43,~~292~~555			812,~~346~~618			711,~~736~~291
Total operating expenses		22,~~189~~694			2322,~~288~~991			4568,~~547~~242			4568,~~053~~044
Other operating income, net		-			891			-			8990
Operating income		5548,~~717~~161			5652,~~052~~148			~~107~~156,~~894~~054			~~113~~165,~~542~~690
Other income (expense):
Foreign currency transactions impact, net		(3114,~~111~~258	)		144,~~766~~068			(1226,~~668~~925	)		59,~~858~~926
Interest income and other income, net		54,~~329~~830			56,~~878~~135			1116,~~915~~745			1117,~~128~~263
Interest expense		(4-	)		(~~110~~58	)		(52	)		(~~200~~258	)
Income before income tax provision		2938,~~931~~733			7662,~~586~~293			~~107~~145,~~089~~822			~~130~~192,~~328~~621
Income tax provision		59,~~714~~594			2014,~~214~~124			2434,~~615~~209			3448,~~874~~998
Net income		2429,~~217~~139			5648,~~372~~169			82111,~~474~~613			95143,~~454~~623
Net income attributable to noncontrolling interests		156,~~356~~248			2013,~~121~~781			3037,~~762~~009			3346,~~023~~804
Net income attributable to Photronics, Inc. shareholders	$	822,~~861~~891		$	3634,~~251~~388		$	5174,~~712~~604		$	6296,~~431~~819
Earnings per share:
Basic	$	0.1540		$	0.5956		$	01.8424		$	1.0157
Diluted	$	0.1539		$	0.5855		$	01.8423		$	1.0055
Weighted-average number of common shares outstanding:
Basic		6057,~~793~~937			61,~~771~~815			6160,~~443~~274			61,~~613~~681
Diluted		6058,~~974~~068			62,~~409~~414			6160,~~817~~567			62,~~346~~369

See accompanying notes to condensed consolidated financial statements.

Table of Contents

PHOTRONICS, INC.

Condensed Consolidated Statements of Comprehensive Income

(in thousands)

(unaudited)

	Three Months Ended						~~Six~~Nine Months Ended
	May 4, 2025			April 28, 2024			May 4, 2025			April 28, 2024
	August 3,			July 28,			August 3,			July 28,
Net income	$	24,217		$	56,372		$	82,474		$	95,454
	2025			2024			2025			2024
Net income	$	29,139		$	48,169		$	111,613		$	143,623
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments		4729,~~124~~171			(396,~~198~~114	)		433,~~208~~380			(713,~~705~~819	)
Other		(6128	)		8248			8(20	)		55103
Net other comprehensive (loss) income		4729,~~063~~143			(396,~~116~~066	)		433,~~216~~360			(713,~~650~~716	)
Comprehensive income		7158,~~280~~282			1742,~~256~~103			86144,~~690~~973			87129,~~804~~907
Less: comprehensive income attributable to noncontrolling interests		2916,~~388~~600			912,~~074~~263			3552,~~954~~555			3244,~~571~~834
Comprehensive income attributable to Photronics, Inc. shareholders	$	41,~~892~~682		$	829,~~182~~840		$	5092,~~736~~418		$	5585,~~233~~073

See accompanying notes to condensed consolidated financial statements.

Table of Contents

PHOTRONICS, INC.

Condensed Consolidated Statements of Equity

(in thousands)

(unaudited)

	Three Months Ended May 4, 2025
	Three Months Ended August 3, 2025
	Photronics, Inc. Shareholders
	Common Stock						Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Non- controlling Interests		Total Equity
													Accumulated
	Shares			Amount
							Additional						Other			Non-
Balance as of February 2, 2025		62,303		$	623		$	515,742		$	731,709		$	(120,325	)	$	366,460	$	1,494,209
	Common Stock						Paid-in			Retained			Comprehensive			controlling		Total
Net income		-			-			-			8,861			-			15,356		24,217
	Shares			Amount			Capital			Earnings			Income (Loss)			Interests		Equity
Other comprehensive income (loss)		-			-			-			-			33,030			14,033		47,063
Shares issued under equity plans		23			-			15			-			-			-		15
Share-based compensation expense		-			-			3,375			-			-			-		3,375
Purchase and retirement of common stock through repurchase program		(3,615	)		(36	)		(29,927	)		(42,147	)		-			-		(72,110	)
Balance as of May 4, 2025		58,711		$	587		$	489,205		$	698,423		$	(87,295	)	$	395,849	$	1,496,769
Net income		-			-			-			22,891			-			6,248		29,139
Other comprehensive income		-			-			-			-			18,791			10,352		29,143
Shares issued under equity plans		54			1			394			-			-			-		395
Share-based compensation expense		-			-			3,294			-			-			-		3,294
Purchase and retirement of common stock through repurchase program		(1,178	)		(12	)		(9,812	)		(10,916	)		-			-		(20,740	)
Balance as of August 3, 2025		57,587		$	576		$	483,081		$	710,398		$	(68,504	)	$	412,449	$	1,538,000

	Three Months Ended April 28, 2024
	Three Months Ended July 28, 2024
	Photronics, Inc. Shareholders
	Common Stock				Additional Paid-in Capital			Retained Earnings		Accumulated Other Comprehensive Loss			Non- controlling Interests			Total Equity
										Accumulated
	Shares		Amount
					Additional					Other			Non-
Balance as of January 28, 2024		61,746	$	617	$	502,903		$	587,299	$	(67,863	)	$	324,098		$	1,347,054
	Common Stock				Paid-in			Retained		Comprehensive			controlling			Total
Net income		-		-		-			36,251		-			20,121			56,372
	Shares		Amount		Capital			Earnings		Loss			Interests			Equity
Other comprehensive income (loss)		-		-		-			-		(28,069	)		(11,047	)		(39,116	)
Shares issued under equity plans		53		1		(208	)		-		-			-			(207	)
Share-based compensation expense		-		-		3,926			-		-			-			3,926
Balance as of April 28, 2024		61,799	$	618	$	506,621		$	623,550	$	(95,932	)	$	333,172		$	1,368,029
Net income		-		-		-			34,388		-			13,781			48,169
Other comprehensive loss		-		-		-			-		(4,548	)		(1,518	)		(6,066	)
Shares issued under equity plans		40		-		(45	)		-		-			-			(45	)
Share-based compensation expense		-		-		3,342			-		-			-			3,342
Balance as of July 28, 2024		61,839	$	618	$	509,918		$	657,938	$	(100,480	)	$	345,435		$	1,413,429

Table of Contents

	Six Months Ended May 4, 2025
	Nine Months Ended August 3, 2025
	Photronics, Inc. Shareholders
	Common Stock						Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Loss			Non- controlling Interests		Total Equity
													Accumulated
	Shares			Amount
							Additional						Other			Non-
	Common Stock						Paid-in			Retained			Comprehensive			controlling		Total
	Shares			Amount			Capital			Earnings			Income (Loss)			Interests		Equity
Balance as of October 31, 2024		61,949		$	619		$	514,757		$	691,807		$	(86,319	)	$	359,895	$	1,480,759
Net income		-			-			-			5174,~~712~~604			-			3037,~~762~~009		82111,~~474~~613
Other comprehensive income (loss)		-			-			-			-			(976	)		5,192		4,216
Other comprehensive income		-			-			-			-			17,815			15,545		33,360
Shares issued under equity plans		~~572~~626			6			(~~714~~319	)		-			-			-		(~~708~~313	)
Share-based compensation expense		-			-			610,~~710~~003			-			-			-		610,~~710~~003
Purchase and retirement of common stock through repurchase program		(34,~~810~~988	)		(3849	)		(3141,~~548~~360	)		(4556,~~096~~013	)		-			-		(7697,~~682~~422	)
Balance as of May 4, 2025		58,711		$	587		$	489,205		$	698,423		$	(87,295	)	$	395,849	$	1,496,769
Balance as of August 3, 2025		57,587		$	576		$	483,081		$	710,398		$	(68,504	)	$	412,449	$	1,538,000

	Six Months Ended April 28, 2024
	Nine Months Ended July 28, 2024
	Photronics, Inc. Shareholders
	Common Stock				Additional Paid-in Capital			Retained Earnings		Accumulated Other Comprehensive Loss			Non- controlling Interests			Total Equity
										Accumulated
	Shares		Amount
					Additional					Other			Non-
	Common Stock				Paid-in			Retained		Comprehensive			controlling			Total
	Shares		Amount		Capital			Earnings		Loss			Interests			Equity
Balance as of October 31, 2023		61,310	$	613	$	502,010		$	561,119	$	(88,734	)	$	300,601		$	1,275,609
Net income		-		-		-			6296,~~431~~819		-			3346,~~023~~804			95143,~~454~~623
Other comprehensive income (loss)		-		-		-			-		(7,198	)		(452	)		(7,650	)
Other comprehensive loss		-		-		-			-		(11,746	)		(1,970	)		(13,716	)
Shares issued under equity plans		~~489~~529		5		(1,~~888~~933	)		-		-			-			(1,~~883~~928	)
Share-based compensation expense		-		-		69,~~499~~841			-		-			-			69,~~499~~841
Balance as of April 28, 2024		61,799	$	618	$	506,621		$	623,550	$	(95,932	)	$	333,172		$	1,368,029
Balance as of July 28, 2024		61,839	$	618	$	509,918		$	657,938	$	(100,480	)	$	345,435		$	1,413,429

See accompanying notes to condensed consolidated financial statements.

Table of Contents

PHOTRONICS, INC.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

	Six Months Ended
	Nine Months Ended
	May 4, 2025			April 28, 2024
	August 3,			July 28
	2025			2024
Cash flows from operating activities:
Net income	$	82111,~~474~~613		$	95143,~~454~~623
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		4059,~~386~~234			4161,~~487~~613
Share-based compensation		610,~~710~~003			69,~~499~~841
Changes in assets and liabilities:
Accounts receivable		412,~~293~~378			(25,~~415~~181	)
Inventories		(46,~~694~~094	)		(45,~~407~~788	)
Other current assets		(68,~~932~~007	)		(42,~~340~~778	)
Accounts payable, accrued liabilities, and other		(1219,~~318~~153	)		(148,~~284~~256	)
Net cash provided by operating activities		~~109~~159,~~919~~974			~~117~~193,~~994~~074
Cash flows from investing activities:
Purchases of property, plant and equipment		(95120,~~749~~588	)		(6387,~~311~~733	)
Purchases of short-term investments		(2796,~~689~~571	)		(66100,~~040~~558	)
Proceeds from maturities of short-term investments		4142,~~482~~148			1344,~~234~~696
Government incentives		1,~~166~~469			1,~~419~~541
Other		(57	)		(64	)
Net cash used in investing activities		(80173,~~847~~599	)		(~~114~~142,~~704~~058	)
Cash flows from financing activities:
Repayments of debt		(17,~~966~~969	)		(24,~~844~~500	)
Common stock repurchases		(7697,~~682~~422	)		-
Proceeds from share-based arrangements		12,~~583~~120			1,~~055~~074
Net settlements of restricted stock awards		(2,~~007~~013	)		(23,~~938~~002	)
Net cash used in financing activities		(95115,~~072~~284	)		(46,~~727~~428	)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash		(110,~~697~~129	)		(36,~~839~~454	)
Net decrease in cash, cash equivalents, and restricted cash		(67,697	)		(5,276	)
Net change in cash, cash equivalents, and restricted cash		(118,780	)		38,134
Cash, cash equivalents, and restricted cash at beginning of period		601,243			501,867
Cash, cash equivalents, and restricted cash at end of period		~~533~~482,~~546~~463			~~496~~540,~~591~~001
Less: Ending restricted cash		2,~~838~~942			2,~~686~~670
Cash and cash equivalents at end of period	$	~~530~~479,~~708~~521		$	~~493~~537,~~905~~331
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased not yet paid	$	1327,~~657~~366		$	79,~~871~~163

See accompanying notes to condensed consolidated financial statements.

Table of Contents

PHOTRONICS, INC.

Notes to Condensed Consolidated Financial Statements

(unaudited)

(in thousands, except share amounts and per share data)

NOTE 1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION

Description of Business

Photronics, Inc. (“Photronics”, “the Company”, “we”, “our”, or “us”) is one of the world’s leading manufacturers of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of ICs and FPDs and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during the fabrication of ICs, a variety of FPDs and, to a lesser extent, other types of electrical and optical components. The Company operates eleven manufacturing facilities, which are located in Taiwan (3), South Korea (1), China (2), the United States (3), and Europe (2).

Basis of Presentation

The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect amounts reported in them. The Company’s estimates are based on historical experience and on various assumptions that the Company believes to be reasonable under the facts and circumstances at the time they are made. Actual results may differ from such estimates. The Company reviews these estimates periodically and reflects any effects of revisions in the period in which they are determined.

Principles of Consolidation

The accompanying unaudited condensed consolidated financial statements (“the financial statements”) have been prepared in accordance with U.S. GAAP for interim financial reporting information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of management, adjustments, all of which are of a normal recurring nature, considered necessary for a fair presentation have been included. The financial statements include the accounts of Photronics, its wholly owned subsidiaries, and the majority-owned subsidiaries, which it controls. All intercompany balances and transactions have been eliminated in consolidation. These financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company’s Form 10-K for the fiscal year ended October 31, 2024, which provides additional information about the Company’s accounting policies and the methods and assumptions used in the Company’s estimates.

The Company’s business is typically impacted during the first quarter of the Company’s fiscal year by the North American, European, and Asian holiday periods, as some customers reduce their development and buying activities during this period. Operating results for the interim periods are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2025.

Recent Accounting Pronouncements

In November 2024, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”) and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, as well as qualitatively describe remaining amounts included in those captions. The guidance in this ~~Update~~ASU will be effective for Photronics in its fiscal year 2028 Form 10-K, with early application of the amendments allowed. The Company is currently evaluating the impact the adoption of this ASU may have on the Company’s consolidated financial statements and related disclosures.

Table of Contents

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, to enhance the transparency and decision usefulness of income tax disclosures. The amendments in this ASU ~~Update~~ related to the rate reconciliation and income taxes paid disclosures to improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. The amendments allow investors to better assess, in their capital allocation decisions, how an entity’s worldwide operations and related tax risks and tax planning and operational opportunities affect its income tax rate and prospects for future cash flows. The guidance in this ~~Update~~ASU will be effective for Photronics in its fiscal year 2026 Form 10-K, with early application of the amendments allowed. The Company is currently evaluating the effect of this ASU adoption on its disclosures.

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance in this ~~Update~~ASU is effective for Photronics in its fiscal year 2025 Form 10-K~~, with early adoption permitted~~. The Company is currently evaluating the effect the adoption of this ASU may have on the Company’s disclosures.

NOTE 2 – ACCOUNTS RECEIVABLE, NET

The components of Accounts Receivable, net at the balance sheet dates are presented below.

	May 4,			October 31,
	August 3,			October 31,
	2025			2024
Accounts Receivable	$	~~165~~161,~~411~~658		$	172,741
Unbilled Receivables		3130,~~737~~401			29,215
Allowance for Credit Losses		(1,~~171~~184	)		(1,126	)
	$	~~195~~190,~~977~~875		$	200,830

NOTE 3 – CASH, CASH EQUIVALENTS AND INVESTMENTS

The Company invests excess cash in bank time deposits and various marketable securities. The Company’s classification of investments is as follows:

-	Maturing within three months or less from the date of purchase	Cash and cash equivalents
-	Maturing, as of the date of purchase, more than three months, but with remaining maturities of less than one year, from the balance sheet date	Short-term investments
-	Maturing one year or more from the balance sheet date	Long-term marketable investments

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows:

Level 1- These are investments where values are based on unadjusted quoted prices for identical assets in an active market the Company has the ability to access.

Level 2- These are investments where values are based on quoted market prices that are not active or model derived valuations in which all significant inputs are observable in active markets.

Level 3- These are investments where values are derived from techniques in which one or more significant inputs are unobservable.

Table of Contents

The following are cash, cash equivalents and investments measured at fair value:

	May 4, 2025						October 31, 2024
	August 3, 2025						October 31, 2024
	Cash and cash equivalents		Short-term investments		Total Fair Value		Cash and cash equivalents		Short-term investments		Total Fair Value
Cash	$	~~188~~171,~~730~~146	$	-	$	~~188~~171,~~730~~146	$	414,074	$	-	$	414,074
Level 1
U.S. Government Securities		285,~~855~~503		924,~~489~~986		3830,~~344~~489		-		-		-
Money market funds		1314,~~421~~782		-		1314,~~421~~782		36,322		-		36,322
Level 2
Commercial paper		5643,~~287~~093		~~668~~2,618		5645,~~955~~711		-		-		-
Time deposits		~~243~~244,~~415~~997		1768,~~542~~673		~~260~~313,~~957~~670		148,089		42,184		190,273
	$	~~530~~479,~~708~~521	$	2796,~~699~~277	$	~~558~~575,~~407~~798	$	598,485	$	42,184	$	640,669
Restricted Cash (1)		2,~~838~~942						2,758
Cash, cash equivalents, and restricted cash	$	~~533~~482,~~546~~463					$	601,243

(1) Restricted cash is included in other assets and primarily relates to ~~land~~customs ~~lease~~requirements ~~agreements~~ and ~~customs~~land ~~requirements~~lease agreements.

Based upon the Company’s intent and ability to hold its time deposits to maturity (which maturities range up to twelve months at purchase), such securities have been classified as held-to-maturity and are carried at amortized cost, which approximates market value. The Company’s U.S. Government Securities, Commercial paper and Money market funds are classified as available-for-sale. Available-for-sale investments are reported at fair value, with unrealized gains or losses (net of tax) reported in Accumulated other comprehensive income (loss). In the event of a sale of these securities, the Company would determine the cost of the investment sold at the specific individual security level and would include any gain or loss in Interest income and other income, net, where the Company also reports periodic interest earned and the amortization (accretion) of discounts (premiums) related to these investments. For the periods ended ~~May~~August 43, 2025, and October 31, 2024, the unrealized gains or losses related to short-term investments were immaterial.

NOTE 4 - INVENTORIES

The components of Inventories at the balance sheet dates are presented below.

	May 4, 2025		October 31, 2024
	August 3,		October 31,
Raw materials	$	59,938	$	56,128
	2025		2024
Work in process		1,239		398
Raw materials	$	61,908	$	56,128
Finished goods		24		1
Work in process		1,560		398
	$	61,201	$	56,527
Finished goods		22		1
	$	63,490	$	56,527

Table of Contents

NOTE 5 - PROPERTY, PLANT AND EQUIPMENT, NET

Presented below are the components of Property, plant and equipment, net at the balance sheet dates.

	May 4, 2025			October 31, 2024
	August 3,			October 31,
Land	$	12,216		$	11,419
	2025			2024
Buildings and improvements		189,230			188,756
Land	$	12,298		$	11,419
Machinery and equipment		2,062,158			1,990,610
Buildings and improvements		192,625			188,756
Leasehold improvements		20,324			19,268
Machinery and equipment		2,143,635			1,990,610
Furniture, fixtures, and office equipment		17,944			18,091
Leasehold improvements		21,037			19,268
Construction in progress		122,474			91,213
Furniture, fixtures, and office equipment		18,598			18,091
		2,424,346			2,319,357
Construction in progress		108,743			91,213
Accumulated depreciation and amortization		(1,616,788	)		(1,574,100	)
		2,496,936			2,319,357
	$	807,558		$	745,257
Accumulated depreciation and amortization		(1,657,948	)		(1,574,100	)
	$	838,988		$	745,257

Information on ROU assets resulting from finance leases, at the balance sheet dates, is presented below. During the first half of 2025, the Company exercised its early buy-out option for a high-end lithography tool and a high-end inspection tool. Please refer to Note 7 for further information.

	May 4, 2025			October 31, 2024
	August 3,			October 31,
	2025			2024
Machinery and equipment	$	55		$	42,815
Accumulated amortization		(4550	)		(10,522	)
	$	105		$	32,293

The following table presents depreciation expense (including the amortization of ROU assets), related to property, plant and equipment incurred during the reporting periods.

	Three Months Ended				~~Six~~Nine Months Ended
	May 4, 2025		April 28, 2024		May 4, 2025		April 28, 2024
	August 3,		July 28,		August 3,		July 28,
Depreciation Expense	$	19,505	$	20,689	$	40,207	$	41,294
	2025		2024		2025		2024
Depreciation Expense	$	18,764	$	20,036	$	58,971	$	61,332

NOTE 6 - PDMCX JOINT VENTURE

In January 2018, Photronics, Inc., through its wholly -owned Photronics Singapore PTE. LTD. subsidiary (hereinafter, within this Note “we”, “Photronics”, “us”, or “our”), and DNP, through its wholly owned subsidiary DNP Asia Pacific PTE, Ltd., entered into a joint venture under which DNP obtained a 49.99% interest in the Company’s IC business in Xiamen, China. The joint venture, which the Company refers to as “PDMCX”, was established to develop and manufacture photomasks for semiconductors. The Company entered into this joint venture to enable the Company to compete more effectively for the merchant photomask business in China, and to benefit from the additional resources and investment that DNP provides to enable the Company to offer advanced-process technology to the Company’s customers.

Under the joint venture agreement, should either Photronics’ or DNP’s ownership interest fall below 20.0% for a period of more than six consecutive months, such party (an “exiting party”) has the option to sell to the other party, and the other party has the option to purchase from such exiting party, the exiting party’s remaining ownership interest. In either case, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance.

Table of Contents

The following table presents the net income the Company recorded from the operations of PDMCX during the reporting periods.

	Three Months Ended				~~Six~~Nine Months Ended
	May 4, 2025		April 28, 2024		May 4, 2025		April 28, 2024
	August 3,		July 28,		August 3,		July 28,
Net income from PDMCX	$	7,557	$	5,464	$	10,925	$	11,928
	2025		2024		2025		2024
Net income from PDMCX	$	3,485	$	4,369	$	14,410	$	16,296

As required by the guidance in ASC Topic 810 - “Consolidation”, the Company evaluated the Company’s involvement in PDMCX for the purpose of determining whether the Company should consolidate its results in the Company’s financial statements. The initial step of the Company’s evaluation was to determine whether PDMCX was a VIE. Due to its lack of sufficient equity at risk to finance its activities without additional subordinated financial support, the Company determined that it is a VIE. Having made this determination, the Company then assessed whether the Company was the primary beneficiary of the VIE and concluded that the Company was the primary beneficiary during the current and prior years reporting periods; thus, as required, the PDMCX financial results have been consolidated with Photronics. The Company’s conclusion was based on the fact that the Company held a controlling financial interest in PDMCX (which resulted from the Company’s having the power to direct the activities that most significantly impacted its economic performance) and had both the obligation to absorb losses and the right to receive benefits that could potentially be significant to PDMCX. The Company’s conclusion that the Company had the power to direct the activities that most significantly affected the economic performance of PDMCX during the current and prior year periods were based on the Company’s right to appoint the majority of its Board of Directors, which has, among others, the powers to manage the business (through its rights to appoint and evaluate PDMCX’s management), incur indebtedness, enter into agreements and commitments, and acquire and dispose of PDMCX’s assets. In addition, as a result of the 50.01% variable interest the Company held during the current and prior year periods, the Company had the obligation to absorb losses, and the right to receive benefits, which could potentially be significant to PDMCX.

The following table presents the carrying amounts of PDMCX assets and liabilities included in the Company’s consolidated balance sheets. General creditors of PDMCX do not have recourse to the assets of Photronics (other than the net assets of PDMCX); therefore, the Company’s maximum exposure to loss from PDMCX is the Company’s interest in the carrying amount of the net assets of the joint venture.

	May 4, 2025				October 31, 2024
	August 3,				October 31,
Classification	Carrying Amount		Photronics Interest		Carrying Amount		Photronics Interest
	2025				2024
Current assets	$	171,717	$	85,876	$	174,059	$	87,047
Classification	Carrying		Photronics		Carrying		Photronics
Noncurrent assets		167,187		83,610		151,039		75,535
	Amount		Interest		Amount		Interest
Total assets		338,904		169,486		325,098		162,582
Current assets	$	169,077	$	84,555	$	174,059	$	87,047
Current liabilities		39,477		19,742		40,691		20,350
Noncurrent assets		166,996		83,515		151,039		75,535
Noncurrent liabilities		2,389		1,195		3,320		1,660
Total assets		336,073		168,070		325,098		162,582
Total liabilities		41,866		20,937		44,011		22,010
Current liabilities		26,852		13,429		40,691		20,350
Net assets	$	297,038	$	148,549	$	281,087	$	140,572
Noncurrent liabilities		2,407		1,204		3,320		1,660
Total liabilities		29,259		14,633		44,011		22,010
Net assets	$	306,814	$	153,437	$	281,087	$	140,572

Table of Contents

NOTE 7 - DEBT

The balance of long-term debt and its current portion iswas comprised of the following finance leases as described below:

	May 4, 2025		October 31, 2024
	August 3,		October 31,
	2025		2024
Principal due:
Next 12 months	$	11	$	17,972
Months 13 – 24	$	12	$	12
Months 25 – 36		74		12
Months 37 – 48		-		1
Months 49 – 60		-		-
Long-term debt		1916		25
Total debt	$	3027	$	17,997
Interest rate at balance sheet date		N/A		N/A
Basis spread on interest rates		N/A		N/A
Interest rate reset		N/A		N/A
Maturity date		N/A		N/A
Periodic payment amount		Varies as Lease matures		Varies as Lease matures
Periodic payment frequency		Monthly		Monthly
Loan collateral (carrying amount) (1)	$	105	$	32,293

⁽¹⁾Represents the carrying amount at the balance sheet date of the related ROU assets, in which the lessors have secured interests.

Finance Leases

In February 2021, the Company entered into a five-year $7.2 million finance lease for a high-end inspection tool. Monthly payments on the lease, which commenced in February 2021, were $0.1 million per month. ~~Upon~~The ~~the~~lease ~~fiftieth~~agreement ~~monthly~~provided ~~payment and prior to payment of the fifty-first monthly payment, the Company could exercise~~ an early buyout option to purchase the tool for $2.4 million. ~~After~~upon the ~~original~~fiftieth ~~term~~monthly orpayment ~~any~~and ~~renewal~~prior ~~periods,~~to the ~~Company~~fifty-first ~~could~~monthly ~~return the tool~~payment, ~~elect~~which ~~to extend~~ the ~~lease, or purchase the tool at its fair market value. The~~ Company exercised ~~the early buyout option to purchase the tool for $2.4 million~~ during the second quarter of fiscal year 2025.

In December 2020, the Company entered into a five-year $35.5 million finance lease for a high-end lithography tool. Monthly payments on the lease, which commenced in January 2021, increased from $0.04 million during the first three months to $0.6 million for the following nine months, followed by forty-eight monthly payments of $0.5 million. The lease agreement provided an early buyout option to purchase the tool for $14.1 million, which the Company exercised during the first quarter of fiscal year 2025.

Xiamen Working Capital Loans

In November 2018, PDMCX obtained approval for revolving, unsecured credit of CNY 200 million ($25 million), pursuant to which PDMCX may enter into separate loan agreements with varying terms to maturity. In December 2022, the Company repaid the Company’s entire outstanding balance of CNY 25.6 million ($3.6 million). The interest rates are variable, based on the CNY Loan Prime Rate of the National Interbank Funding Center. Interest incurred on the loans related to the amount borrowed was eligible for reimbursement through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provided ~~for~~ such reimbursements up to a prescribed limit and duration. This facility is subject to annual reviews and extensions. In ~~August~~July ~~2024~~2025, the Company was issued an extension to the revolving, unsecured credit agreement for CNY 200 million ~~(approximately~~ ~~$27.5~~or USD 25 million) with an expiration date of July 31, ~~2025~~2026. As of ~~May~~August 43, 2025, PDMCX had no outstanding borrowings against the approval.

Table of Contents

NOTE 8 -– REVENUE

The Company recognizes revenue when, or as, control of a good or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those goods or services. The Company accounts for an arrangement as a revenue contract when each party has approved and is committed to perform under the contract, the rights of the contracting parties regarding the goods or services to be transferred and the payment terms are identifiable, the arrangement has commercial substance, and collection of consideration is probable. Substantially all of the Company’s revenue comes from the sales of photomasks. The Company typically contracts with the Company’s customers to sell sets of photomasks, which are comprised of multiple layers, the predominance of which the Company invoices as they ship to customers. As the photomasks are manufactured to customer specifications, they have no alternative use to the Company and, as the Company’s contracts generally provide the Company with the right to payment for work completed to date, the Company recognizes revenue as the Company performs, or “over time,” on most of the Company’s contracts. The Company measures the Company’s performance to date using an input method, which is based on the Company’s estimated costs to complete the various manufacturing phases of a photomask. At the end of a reporting period, there are a number of uncompleted revenue contracts on which the Company has performed; for any such contracts under which the Company is entitled to be compensated for the Company’s costs incurred plus a reasonable profit, the Company recognizes revenue and a corresponding contract asset for such performance. The Company accounts for shipping and handling activities that the Company performs after a customer obtains control of a good as being activities to fulfill the Company’s promise to transfer the good to the customer, rather than as promised services, or performance obligations, under the contract. The Company reports the Company’s revenue net of any sales or similar taxes the Company collects on behalf of governmental entities.

As stated above, photomasks are manufactured to customer specifications in accordance with their proprietary designs; thus, they are individually unique. Due to their uniqueness and other factors, their transaction prices are individually established through negotiations with customers; consequently, the Company’s photomasks do not have standard or “list” prices. The transaction prices of the vast majority of the Company’s revenue contracts include only fixed amounts of consideration. In certain instances, such as when the Company offers a customer an early payment discount, an estimate of variable consideration would be included in the transaction price, but only to the extent that a significant reversal of revenue would not occur when the uncertainty related to the variability was resolved.

Contract Assets, Contract Liabilities, and Accounts Receivable

The Company recognizes a contract asset when its performance under a contract precedes the Company’s receipt of consideration from a customer, or before payment is due, and the right to receive consideration is conditional upon factors other than the passage of time. Contract assets reflect the Company’s transfer of control to customers of photomasks that are in process or completed but not yet shipped to customers. A receivable is recognized when the Company has an unconditional right to payment, which generally occurs upon the shipment of the photomasks. The Company’s contract assets primarily consist of in-process production orders and fully manufactured photomasks which have not yet shipped, for which the Company has an enforceable right to consideration (including a reasonable profit) in the event the in-process orders are cancelled by customers. On an individual contract basis, the Company nets contract assets with contract liabilities (deferred revenue) for financial reporting purposes. The Company did not identify impairment indicators for any outstanding contract assets during the three-month or ~~six~~nine-month periods ended ~~May~~August 43, 2025, or ~~April~~July 28, 2024.

Table of Contents

The following table provides information about the Company’s contract balances at the balance sheet dates.

Classification	May 4, 2025		October 31, 2024
	August 3,		October 31,
Classification	2025		2024
Contract Assets
Other current assets	$	1415,~~837~~233	$	11,532
Contract Liabilities
Accrued liabilities	$	11,~~893~~349	$	12,375
Other liabilities		5,~~765~~760		8,910
	$	17,~~658~~109	$	21,285

The Company did not recognize any revenue from performance obligations satisfied in the previous periods. The following table presents revenue recognized from contract liabilities that existed at the beginning of the reporting periods.

	Three Months Ended				~~Six~~Nine Months Ended
	May 4, 2025		April 28, 2024		May 4, 2025		April 28, 2024
	August 3,		July 28,		August 3,		July 28,
Revenue recognized from beginning liability	$	2,589	$	6,495	$	5,745	$	7,746
	2025		2024		2025		2024
Revenue recognized from beginning liability	$	1,873	$	7,057	$	7,273	$	11,072

The Company generally records accounts receivable at their billed amounts. All outstanding past due customer invoices are reviewed for collectability during, and at the end of, every reporting period. To the extent the Company believes a loss on the collection of a customer invoice is probable, the Company would record the loss and credit an allowance for credit losses. In the event that an amount is determined to be uncollectible, the Company charges the allowance for credit losses and derecognizes the related receivable. The Company did not incur any credit losses on the Company’s accounts receivable during the three-month or ~~six~~nine-month periods ended ~~May~~August 43, 2025, or ~~April~~July 28, 2024.

The Company’s invoice terms generally range from net thirty to ninety days, depending on both the geographic market in which the transaction occurs and the Company’s payment agreements with specific customers. In the event that the Company’s evaluation of a customer’s business prospects, and financial condition indicate that the customer presents a collectability risk, the Company will modify terms of sale, which may require payment in advance of performance. At the time of adoption, the Company elected the practical expedient allowed under ASC Topic 606 “Revenue from Contracts with Customers” (“Topic 606”) that permits the Company not to adjust a contract’s promised amount of consideration to reflect a financing component when the period between when the Company transfers control of goods or services to customers and when the Company is paid is one year or less.

In instances when the Company is paid in advance of the Company’s performance, the Company records a contract liability and, as allowed under the practical expedient in Topic 606, recognizes interest expense only if the period between when the Company receives payment from the customer and the date when the Company expects to be entitled to the payment is greater than one year. Historically, advance payments the Company has received from customers have generally not preceded the completion of the Company’s performance obligations by more than one year.

Table of Contents

Disaggregation of Revenue

The following tables present the Company’s revenue for the three-month and ~~six~~nine-month periods ended ~~May~~August 43, 2025, and ~~April~~July 28, 2024, disaggregated by product type, geographic origin, and timing of recognition.

Three Months Ended

~~Six~~Nine Months Ended

Revenue by Product Type

May 4, 2025

April 28, 2024

May 4, 2025

April 28, 2024

August 3,

July 28,

August 3,

July 28,

Revenue by Product Type

2025

2024

2025

2024

High-end

5953,~~299~~648

5849,~~042~~499

~~119~~173,~~405~~053

~~118~~168,~~918~~417

Mainstream

9694,~~578~~176

~~102~~106,~~886~~385

~~190~~284,~~429~~605

~~199~~305,~~599~~984

Total IC

~~155~~147,~~877~~824

~~160~~155,~~928~~884

~~309~~457,~~834~~658

~~318~~474,~~517~~401

FPD

High-end

4353,~~613~~486

4748,~~977~~394

93146,~~292~~778

98146,~~593~~987

Mainstream

119,~~502~~084

86,~~095~~706

2029,~~004~~088

1622,~~224~~930

Total FPD

5562,~~115~~570

5655,~~072~~100

~~113~~175,~~296~~866

~~114~~169,~~817~~917

210,~~992~~394

~~217~~210,~~000~~984

~~423~~633,~~130~~524

~~433~~644,~~334~~318

	Three Months Ended				~~Six~~Nine Months Ended
Revenue by Geographic Origin*	May 4, 2025		April 28, 2024		May 4, 2025		April 28, 2024
	August 3,		July 28,		August 3,		July 28,
Taiwan	$	75,060	$	75,410	$	148,094	$	150,376
Revenue by Geographic Origin*	2025		2024		2025		2024
China		58,742		58,693		112,300		116,829
Taiwan	$	68,429	$	68,182	$	216,524	$	218,557
South Korea		37,594		39,286		77,831		79,621
China		50,618		55,301		162,919		172,131
United States		30,727		33,314		67,626		66,047
South Korea		43,716		38,412		121,547		118,033
Europe		8,153		9,926		16,094		19,631
United States		37,754		38,833		105,379		104,880
Other		716		371		1,185		830
Europe		9,050		9,759		25,143		29,390
	$	210,992	$	217,000	$	423,130	$	433,334
Other		827		497		2,012		1,327
	$	210,394	$	210,984	$	633,524	$	644,318

* This table disaggregates revenue by the location in which it was earned.

	Three Months Ended				~~Six~~Nine Months Ended
Revenue by Timing of Recognition	May 4, 2025		April 28, 2024		May 4, 2025		April 28, 2024
	August 3,		July 28,		August 3,		July 28,
Over time	$	200,188	$	211,189	$	405,264	$	414,716
Revenue by Timing of Recognition	2025		2024		2025		2024
At a point in time		10,804		5,811		17,866		18,618
Over time	$	201,986	$	202,177	$	607,249	$	616,893
		210,992		217,000		423,130		433,334
At a point in time		8,408		8,807		26,275		27,425
		210,394		210,984		633,524		644,318

Contract Costs

The Company pays commissions to third-party sales agents for certain sales they procure on the Company’s behalf. However, the basis of the commissions isare the transaction prices of the sales, which are completed in less than one year; thus, no relationship is established with a customer that will result in future business. Therefore, the Company does not recognize any portion of these sales commissions as costs of obtaining a contract, nor does the Company currently foresee other circumstances under which the Company would recognize contract obtainment costs as assets.

Table of Contents

Remaining Performance Obligations

As the Company is typically required to fulfill customer orders within a short time period, the Company’s backlog of orders is generally not in excess of one to two weeks for IC photomasks and two to three weeks for FPD photomasks. However, the demand for some IC photomasks can extend beyond the traditional time period; thus, the backlog, in some individual cases, can extend to as long as two to three months. More recently however, backlogs for most high demand products have returned to historical levels of less than a month. As allowed under ASC 606 – Revenue Contracts with Customers, the Company has elected not to disclose the Company’s remaining performance obligations, which represent the costs associated with the completion of the manufacturing process of in-process photomasks related to contracts that have an original duration of one year or less.

Product Warranties

The Company’s photomasks are sold under warranties that generally range from one to twenty-four months. The Company warrants that the Company’s photomasks conform to customer specifications, and the Company will typically repair, replace, or issue a refund for any photomasks that fail to do so. The warranties do not represent separate performance obligations in the Company’s revenue contracts. Historically, customer claims under warranties have been immaterial.

NOTE 9 - SHARE-BASED COMPENSATION

On April 2, 2025, at its annual meeting of shareholders, the shareholders of Photronics, Inc., approved the Company’s 2025 Equity Incentive Compensation Plan (the “2025 Plan”) under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted. Shares to be issued under the 2025 Plan may be authorized and unissued shares, issued shares that have been re-acquired by the Company (in the open market or in private transactions), or a combination thereof. The maximum number of shares of common stock that may be issued under the 2025 Plan is five million shares. At the time of approval of the 2025 Plan, the Company’s 2016 Equity Incentive Compensation Plan (which was largely replicated by the 2025 Plan) was due to expire in early 2026, and had a limited quantity of shares remaining available for issuance. Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of Photronics or its subsidiaries. In the event of a change in control (as defined in the 2025 Plan), the vesting of awards may be accelerated. The 2025 Plan prohibits further awards from being issued under prior plans. The table below presents information on the Company’s share-based compensation expenses.

Three Months Ended

~~Six~~Nine Months Ended

May 4,

April 28,

May 4,

April 28,

August 3,

July 28,

August 3,

July 28,

2025

2024

2025

2024

Expense reported in:

Cost of goods sold

~~785~~816

~~669~~683

12,~~562~~378

1,~~263~~946

Selling, general, and administrative

2,~~288~~174

2,~~987~~388

46,~~556~~729

47,~~737~~126

Research and development

~~302~~304

~~270~~271

~~592~~896

~~499~~769

Total expense incurred

3,~~375~~294

3,~~926~~342

610,~~710~~003

69,~~499~~841

Expense by award type:

Restricted stock awards

2,~~809~~943

3,~~926~~342

69,~~086~~029

69,~~499~~841

Restricted stock units

~~509~~294

~~509~~803

Employee stock purchase plan

~~115~~171

Total expense incurred

3,~~375~~294

3,~~926~~342

610,~~710~~003

69,~~499~~841

Income tax benefits on share-based compensation

~~406~~461

323

~~852~~1,313

~~421~~745

Table of Contents

Restricted Stock Awards

The Company has historically granted restricted stock awards on a periodic basis, the restrictions on which typically lapse over a service period of one to four years. The fair value of the awards is determined on the date of grant, based on the closing price of the Company’s common stock. The table below presents information on the Company’s restricted stock awards.

	Three Months Ended				~~Six~~Nine Months Ended
	May 4,		April 28,		May 4,		April 28,
	August 3,		July 28,		August 3,		July 28,
	2025		2024		2025		2024
Number of shares granted in period		~~237,738~~-		-		583,238		825,050
Weighted-average grant-date fair value of awards (in dollars per share)	$	~~21.28~~-	$	-	$	23.42	$	29.77
Compensation cost not yet recognized	$	2724,~~028~~414	$	2825,~~695~~750	$	2724,~~028~~414	$	2825,~~695~~750
Weighted-average amortization period for cost not yet recognized (in years)		32.08		32.19		32.08		32.19
Shares outstanding at balance sheet date		1,~~439~~421,~~672~~897		1,~~560~~513,~~540~~827		1,~~439~~421,~~672~~897		1,~~560~~513,~~540~~827

Restricted Stock Units

Commencing Q2 FY25, the ~~company~~Company began granting restricted stock units, the restrictions on which typically lapse over a service period of one to four years. The fair value of the awards is determined on the date of grant, based on the closing price of the Company’s common stock. The table below presents information on the Company’s restricted stock unit awards.

	Three Months Ended				~~Six~~Nine Months Ended
	May 4,		April 28,		May 4,		April 28,
	August 3,		July 28,		August 3,		July 28,
	2025		2024		2025		2024
Number of units granted in period		52109,~~836~~830		-		52162,~~836~~666		-
Weighted-average grant-date fair value of awards (in dollars per share)	$	2218.5221	$	-	$	2219.5261	$	-
Compensation cost not yet recognized	$	~~681~~2,387	$	-	$	~~681~~2,387	$	-
Weighted-average amortization period for cost not yet recognized (in years)		03.83		-		03.83		-
Restricted stock units outstanding at balance sheet date		33132,~~966~~474		-		33132,~~966~~474		-

Stock Options

Option awards generally vest in one to four years and have a ten-year contractual term. All incentive and non-qualified stock option grants must have an exercise price no less than the market value of the underlying common stock on the date of grant. The grant-date fair values of options are based on closing prices of the Company’s common stock on the dates of grant and are calculated using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of the Company’s common stock. The Company uses historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that options are expected to remain outstanding. The risk-free rate of return for the estimated term of an option is based on the U.S. Treasury yield curve in effect at the date of grant. The table below presents information on the Company’s stock options.

	Three Months Ended				~~Six~~Nine Months Ended
	May 4,		April 28,		May 4,		April 28,
	August 3,		July 28,		August 3,		July 28,
	2025		2024		2025		2024
Number of options granted in period		-		-		-		-
Cash received from options exercised	$	26400	$	~~119~~20	$	1,~~298~~698	$	1,~~055~~074
Compensation cost not yet recognized	$	-	$	-	$	-	$	-
Weighted-average amortization period for cost not yet recognized (in years)		-		-		-		-

Table of Contents

Information regarding outstanding and exercisable option awards as of ~~May~~August 43, 2025, is presented below.

Options

Weighted Average Exercise Price

Weighted Average Remaining Contractual Life (in years)

Aggregate Intrinsic Value

Weighted

Outstanding and exercisable at May 4, 2025

148,075

10.72

1.80

1,259

Weighted

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

Options

Price

Life (in years)

Value

Outstanding and exercisable at August 3, 2025

115,075

10.31

1.88

1,091

NOTE 10 - INCOME TAXES

The Company calculates its provision for income taxes at the end of each interim reporting period on the basis of an estimated annual effective tax rate adjusted for tax items that are discrete to each period. The table below sets forth the primary reasons that the Company’s effective income tax rates differed from the U.S. statutory tax rates in effect during the periods ended ~~May~~August 43, 2025, and ~~April~~July 28, 2024.

Reporting Period	U.S. Statutory Tax Rates		Photronics Effective Tax Rates	~~Photronics Effective Tax Rates~~	Primary Reasons for Differences	~~Primary Reasons for Differences~~
Three months ended May 4, 2025		21.0%			19.1%	Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions, and changes in uncertain tax positions in non-U.S. jurisdictions.
Three months ended August 3, 2025	21.0%		24.8%		Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions, and changes in uncertain tax positions in non-U.S. jurisdictions.
Three months ended April 28, 2024		21.0%			26.4%	Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions and the establishment of uncertain tax positions in non-U.S. jurisdictions.
Three months ended July 28, 2024	21.0%		22.7%		Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions and the establishment of uncertain tax positions in non-U.S. jurisdictions.
Six months ended May 4, 2025		21.0%			23.0%	Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions, and changes in uncertain tax positions in non-U.S. jurisdictions.
Nine Months Ended August 3, 2025	21.0%		23.5%		Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions, and changes in uncertain tax positions in non-U.S. jurisdictions.
Six months ended April 28, 2024		21.0%			26.8%	Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions, and the establishment of uncertain tax positions in non-U.S. jurisdictions.
Nine Months Ended July 28, 2024	21.0%		25.4%		Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions, and the establishment of uncertain tax positions in non-U.S. jurisdictions.

Table of Contents

United States Tax Law Change

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. The OBBBA includes a number of tax provisions and multiple effective dates commencing in fiscal year 2026. The Company is currently evaluating the effect of the OBBBA enactment on its consolidated financial statements.

Uncertain Tax Positions

Although the timing of reversal of uncertain tax positions may be ~~uncertain,~~ asindeterminate ~~they~~at ~~can~~this ~~be dependent upon the settlement of tax audits~~time, the Company believes ~~that~~ the ~~amount~~resolution of ~~uncertain~~these ~~tax~~uncertainties ~~positions~~in ~~(including~~a ~~interest~~manner ~~and~~inconsistent ~~penalties,~~with ~~and~~our ~~net~~expectations ofcould ~~tax~~have ~~benefits)~~a ~~that~~material ~~may~~impact beon ~~resolved~~our ~~over~~results ~~the~~of ~~next~~operations ~~twelve~~and ~~months~~financial ~~is immaterial~~condition. Resolution of these uncertain tax positions may result from either or both the lapses of statutes of limitations and tax settlements. The Company is no longer subject to tax authority examinations in the U.S., major foreign, or state tax jurisdictions for years prior to fiscal year 2019. The table below presents information on unrecognized tax benefits as of the balance sheet dates.

	May 4, 2025		October 31, 2024
	August 3, 2025		October 31, 2024
Unrecognized tax benefits related to uncertain tax positions	$	1415,~~006~~028	$	14,720
Unrecognized tax benefits that, if recognized, would impact the effective tax rate	$	1415,~~006~~028	$	14,720
Accrued interest and penalties related to uncertain tax positions	$	1,~~327~~484	$	1,028

Subsequent to the balance sheet date, the Company was notified that it will be subject to a routine income tax audit by authorities in a foreign jurisdiction. The audit process is in its initial stages, and at this time, the Company is unable to reasonably estimate any potential impact from the tax audit.

NOTE 11 - EARNINGS PER SHARE

The following sets forth the computation of basic and diluted earnings per share:

	Three Months Ended				~~Six~~Nine Months Ended
	May 4, 2025		April 28, 2024		May 4, 2025		April 28, 2024
	August 3,		July 28,		August 3,		July 28,
Net income attributable to Photronics, Inc. shareholders	$	8,861	$	36,251	$	51,712	$	62,431
	2025		2024		2025		2024
Net income attributable to Photronics, Inc. shareholders	$	22,891	$	34,388	$	74,604	$	96,819
Weighted-average common shares outstanding (in thousands):
Basic		6057,~~793~~937		61,~~771~~815		6160,~~443~~274		61,~~613~~681
Effect of dilutive securities:
Share-based awards		~~181~~131		~~638~~599		~~374~~293		~~733~~688
Dilutive common shares		~~181~~131		~~638~~599		~~374~~293		~~733~~688
Weighted-average common shares - Diluted		6058,~~974~~068		62,~~409~~414		6160,~~817~~567		62,~~346~~369
Earnings per share attributable to Photronics, Inc. shareholders:
Basic	$	0.1540	$	0.5956	$	01.8424	$	1.0157
Diluted	$	0.1539	$	0.5855	$	01.8423	$	1.0055

The table below illustrates the outstanding weighted-average share-based awards that were excluded from the calculation of diluted earnings per share because their exercise price exceeded the average market value of the common shares for the period or, under application of the treasury stock method, they were otherwise determined to be antidilutive.

	Three Months Ended				~~Six~~Nine Months Ended
	May 4, 2025		April 28, 2024		May 4, 2025		April 28, 2024
	August 3,		July 28,		August 3,		July 28,
Share-based payment awards in shares		1,099		-		793		121
	2025		2024		2025		2024
Total potentially dilutive shares excluded		1,099		-		793		121
Share-based payment awards, in shares		1,094		551		894		264
Total potentially dilutive shares excluded		1,094		551		894		264

Table of Contents

NOTE 12 - COMMITMENTS AND CONTINGENCIES

As of ~~May~~August 43, 2025, the Company’s unrecognized commitments for the acquisition of property, plant and equipment were $~~164~~147.82 million, including commitments with a remaining term in excess of one year of approximately $~~122~~32.25 million. This amount does not include the Company’s commitments under the Company’s debt and lease arrangements.

The Company is subject to various other claims that arise in the ordinary course of business. The Company believes that the Company’s potential liability under such claims, individually or in the aggregate, will not have a material effect on the Company’s consolidated financial statements.

NOTE 13 - CHANGES IN ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME BY COMPONENT

The following tables set forth the changes in the Company’s accumulated other comprehensive (loss) income by component (net of tax) for the three-month and ~~six~~nine-month periods ended ~~May~~August 43, 2025, and ~~April~~July 28, 2024.

	Three Months Ended May 4, 2025
	Three Months Ended August 3, 2025
	Foreign Currency Translation Adjustments			Other			Total
	Foreign Currency
Balance at February 2, 2025	$	(119,629	)	$	(696	)	$	(120,325	)
	Translation
Other comprehensive (loss) income		47,124			(61	)		47,063
	Adjustments			Other			Total
Other comprehensive (loss) income attributable to noncontrolling interests		(14,063	)		30			(14,033	)
Balance at May 4, 2025	$	(86,568	)	$	(727	)	$	(87,295	)
Other comprehensive (loss) income		29,171			(28	)		29,143
Other comprehensive (loss) income attributable to noncontrolling interests		(10,365	)		13			(10,352	)
Balance at August 3, 2025	$	(67,762	)	$	(742	)	$	(68,504	)

	Three Months Ended April 28, 2024
	Three Months Ended July 28, 2024
	Foreign Currency Translation Adjustments			Other			Total
	Foreign Currency
Balance at January 28, 2024	$	(67,160	)	$	(703	)	$	(67,863	)
	Translation
Other comprehensive (loss) income		(39,198	)		82			(39,116	)
	Adjustments			Other			Total
Other comprehensive (loss) income attributable to noncontrolling interests		11,087			(40	)		11,047
Balance at April 28, 2024	$	(95,271	)	$	(661	)	$	(95,932	)
Other comprehensive (loss) income		(6,114	)		48			(6,066	)
Other comprehensive (loss) income attributable to noncontrolling interests		1,534			(16	)		1,518
Balance at July 28, 2024	$	(99,851	)	$	(629	)	$	(100,480	)

	Six Months Ended May 4, 2025
	Nine Months Ended August 3, 2025
	Foreign Currency Translation Adjustments			Other			Total
	Foreign Currency
	Translation
	Adjustments			Other			Total
Balance at October 31, 2024	$	(85,587	)	$	(732	)	$	(86,319	)
Other comprehensive income		4,208			8			4,216
Other comprehensive (loss) income		33,380			(20	)		33,360
Other comprehensive loss attributable to noncontrolling interests		(5,189	)		(3	)		(5,192	)
Other comprehensive (loss) income attributable to noncontrolling interests		(15,555	)		10			(15,545	)
Balance at May 4, 2025	$	(86,568	)	$	(727	)	$	(87,295	)
Balance at August 3, 2025	$	(67,762	)	$	(742	)	$	(68,504	)

Table of Contents

	Six Months Ended April 28, 2024
	Nine Months Ended July 28, 2024
	Foreign Currency Translation Adjustments			Other			Total
	Foreign Currency
	Translation
	Adjustments			Other			Total
Balance at October 31, 2023	$	(88,044	)	$	(690	)	$	(88,734	)
Other comprehensive (loss) income		(713,~~705~~819	)		55103			(713,~~650~~716	)
Other comprehensive (loss) income attributable to noncontrolling interests		~~478~~2,012			(2642	)		~~452~~1,970
Balance at April 28, 2024	$	(95,271	)	$	(661	)	$	(95,932	)
Balance at July 28, 2024	$	(99,851	)	$	(629	)	$	(100,480	)

NOTE 14 -– SHARE REPURCHASE PROGRAM

In September 2020, the Company’s Board of Directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b-18 of the Exchange Act. The repurchase authorization by the Board of Directors has no expiration date, does not obligate the Company to acquire any common stock, and is subject to market conditions. From September 2020 through October 2022, the Company repurchased 5.8 million shares at a cost of $68.3 million. No shares were repurchased during the three- or nine-month periods ended July 28, 2024. In August 2024, the Board of Directors authorized an increase to the Company’s existing share repurchase program from the remaining $31.7 million up to $100 million. During the three-month period ended ~~May~~August 43, 2025, the Company repurchased 31.62 million shares at a cost of $7220.17 million pursuant to Rule 10b-18 of the Exchange Act. During the ~~six~~nine-month period ended ~~May~~August 43, 2025, the Company repurchased ~~3.8~~5 million shares at a cost of $7697.74 million pursuant to Rule 10b-18 of the Exchange Act. ~~All~~In ~~shares~~June ~~repurchased~~2025, ~~under~~ the ~~program~~Board ~~have~~of ~~been~~Directors ~~retired.~~authorized Noan ~~shares~~additional ~~were~~$25 ~~repurchased~~million ~~during~~share ~~the~~repurchase. ~~three-~~As ora ~~six-month period ended April 28~~result, ~~2024.~~as As of ~~May~~August 43, 2025, $2327.36 million remained available under this authorization. ~~for~~All shares repurchased under the ~~repurchase~~program ofhave ~~additional~~been ~~shares~~retired.

Table of Contents

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

Management’s discussion and analysis (“MD&A”) of the Company’s financial condition and results of operations should be read in conjunction with its condensed consolidated financial statements and related notes. Various sections of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company’s Form 10-K for fiscal year 2024), that may cause actual results to materially differ from these expectations. See “Forward-Looking Statements”.

We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as photonics, microelectronic mechanical systems, and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and display designs and applications, particularly as they relate to the semiconductor industry’s migration to more advanced product innovation, design methodologies, and fabrication processes. The demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or display sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or display designs could reduce demand for photomasks ‒ even if the demand for semiconductors and displays increases. Advances in semiconductor, display, and photomask design and production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been characterized by, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices, with a concomitant effect on revenue and profitability.

We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog, typically two to three weeks of backlog for FPD photomasks and one to two weeks for IC photomasks. However, the demand for some IC photomasks has in the past expanded beyond the industry’s capacity to supply them within the traditional time period; thus, for some products, the backlog can expand to as long as two to three months.

The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry’s transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.

Table of Contents

Results of Operations

The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.

	Three Months Ended									~~Six~~Nine Months Ended
	May 4,			February 2,			April 28,			May 4,			April 28,
	August 3,			May 4,			July 28,			August 3,			July 28,
	2025			2025			2024			2025			2024
Revenue		100.0	%		100.0	%		100.0	%		100.0	%		100.0	%
Cost of goods sold		6366.13			6463.41			6364.54			6364.76			63.47
Gross profit		3633.97			3536.69			3635.56			3635.34			36.63
Operating expenses:
Selling, general, and administrative		8.68			98.06			89.82			8.8			8.68
Research and development		12.90			21.09			21.07			2.0			1.8
Operating income		2622.49			2426.64			2524.87			2524.56			2625.27
Other income (expense), net		(124.25	)		11(12.82	)		94.58			(01.26	)		34.92
Income before income tax provision		1418.24			3614.42			3529.35			2523.30			3029.19
Income tax provision		24.76			82.97			96.37			5.84			87.06
Net income		1113.58			2711.5			2622.08			1917.56			22.03
Net income attributable to noncontrolling interests		7.3.0			7.3			96.35			75.38			7.63
Net income attributable to Photronics, Inc. shareholders		410.29	%		204.2	%		16.73	%		1211.28	%		1415.40	%

Note: All the following tabular comparisons, unless otherwise indicated, are for the three months ended ~~May~~August 43, 2025 (Q2Q3 FY25), ~~February~~May 24, 2025 (Q1Q2 FY25) and ~~April~~July 28, 2024 ~~(Q2~~ (Q3 FY24) and for the ~~six~~nine months ended ~~May~~August 43, 2025 (YTD FY25) and ~~April~~July 28, 2024 (YTD FY24).

Revenue

Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal year by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.

Table of Contents

The following tables present changes in revenue disaggregated by product type and geographic origin, in Q2Q3 FY25 from revenue in prior reporting periods.

Changes in Revenue by Product Type ($ in millions)

	Q2 FY25 compared with Q1 FY25								Q2 FY25 compared with Q2 FY24						YTD FY25 compared with YTD FY24
	Q3 FY25 compared with Q2 FY25								Q3 FY25 compared with Q3 FY24						YTD FY25 compared with YTD FY24
	Revenue in		Increase			Percent			Increase			Percent			Revenue in		Increase			Percent
	Q2 FY25		(Decrease)			Change			(Decrease)			Change			YTD FY25		(Decrease)			Change
	Q3 FY25		(Decrease)			Change			(Decrease)			Change			YTD FY25		(Decrease)			Change
IC
High-end*	$	5953.36	$	(05.87	)		(19.35	)%	$	14.31			28.24	%	$	~~119~~173.41	$	04.56			02.48	%
Mainstream		9694.62		(2.74	)		(2.95	)%		(612.32	)		(611.15	)%		~~190~~284.46		(921.24	)		(47.60	)%
Total IC	$	~~155~~147.98	$	1(8.91	)		1(5.2	)%	$	(58.01	)		(35.12	)%	$	~~309~~457.87	$	(816.78	)		(23.75	)%
FPD
High-end*	$	4353.65	$	(69.19	)		~~(12~~22.26	)%	$	(45.41	)		(910.15	)%	$	93146.38	$	(50.32	)		(50.41	)%
Mainstream		119.51		3(2.14	)		35(21.30	)%		32.4			4235.15	%		2029.0		36.82			2326.39	%
Total FPD	$	5562.16	$	(37.05	)		(513.35	)%	$	(17.05	)		(113.76	)%	$	~~113~~175.38	$	(16.50	)		~~(1.~~3.5	)%
Total Revenue	$	~~211~~210.04	$	(10.16	)		(0.53	)%	$	(6.0.6	)		(20.83	)%	$	~~423~~633.15	$	(10.28	)		(21.47	)%

* High-end photomasks typically have higher ASPs than mainstream products.

Changes in Revenue by Geographic Origin ($ in millions) **

	Q2 FY25 compared with Q1 FY25								Q2 FY25 compared with Q2 FY24						YTD FY25 compared with YTD FY24
	Q3 FY25 compared with Q2 FY25								Q3 FY25 compared with Q3 FY24						YTD FY25 compared with YTD FY24
	Revenue in		Increase			Percent			Increase			Percent			Revenue in		Increase			Percent
	Q2 FY25		(Decrease)			Change			(Decrease)			Change			YTD FY25		(Decrease)			Change
	Q3 FY25		(Decrease)			Change			(Decrease)			Change			YTD FY25		(Decrease)			Change
Taiwan	$	7568.14	$	2(6.06	)		2(8.8	)%	$	(0.42	)		(0.54	)%	$	~~148~~216.15	$	(2.30	)		(10.59	)%
China		5850.76		5(8.21	)		9(13.78	)%		-(4.7	)		0(8.15	)%		~~112~~162.39		(49.52	)		(35.94	)%
South Korea		3743.67		(26.51	)		(616.63	)%		(15.63	)		(413.38	)%		77121.85		(13.85	)		(23.20	)%
United States		3037.78		(67.20	)		~~(16~~22.79	)%		(21.50	)		(72.8	)%		67105.64		10.65			20.45	%
Europe		89.21		0.29			211.70	%		(10.87	)		(177.93	)%		1625.12		(34.63	)		(1814.05	)%
Other		0.78		0.21			5215.35	%		0.3			9366.04	%		1.2.0		0.47			4251.86	%
	$	~~211~~210.04	$	(10.16	)		(0.53	)%	$	(6.0.6	)		(20.83	)%	$	~~423~~633.15	$	(10.28	)		(21.47	)%

** This table disaggregates revenue by the location in which it was earned.

Revenue in Q2Q3 FY25 of $~~211~~210.04 million represented a decrease of 0.53% compared with Q1Q2 FY25 ~~primarily~~and ~~due~~Q3 toFY24, ~~high-end~~as weakness in IC ~~and~~revenue was partially offset by strength in FPD ~~revenue,~~demand. ~~and~~Revenue in YTD FY25 of $633.5 million represented a decrease of 21.87% ~~from~~compared Q2to the same period in FY24, primarily due to IC mainstream ~~weakness~~ revenue decrease in ICAsia, offset slightly by an increase in FPD mainstream revenue.

IC revenue ~~increased~~decreased $18.91 million or 15.2 % in Q2Q3 FY25 from Q1Q2 FY25, primarily due to ana ~~increase~~decrease in both high-end and mainstream ofrevenue ~~$2.7~~in ~~million~~Asia orreflecting 2continued headwinds experienced in 2025, including geopolitical trade restrictions and unresolved tariff negotiations.~~9%.~~ Comparing Q2Q3 FY25 to Q2Q3 FY24, IC revenue decreased $58.01 million or 35.12% , mainly due to reduced mainstream demand in Asia, ~~and~~partially offset by strong high-end order patterns in the United States. IC revenue decreased $816.78 million or 23.7 5% in YTD FY25 from YTD FY24, mainly due to reduced mainstream demand in Asia and Europe, partially offset by increased high-end demand in the United States.

FPD revenue ~~decreased~~increased $37.05 million or 513.35% in Q2Q3 FY25 from Q1Q2 FY25, ~~and~~driven by an increase in high-end of $19.09 million or 122.76%. ~~from~~Comparing Q2Q3 ~~FY24~~FY25 asto aQ3 ~~result~~FY24, ofFPD ~~industry~~revenue ~~softness~~increased in$7.5 ~~High-end~~million ~~products~~or 13.6%, ~~partially~~driven ~~offset~~ by increased demand in ~~Mainstream~~both ~~products~~ high-end and mainstream markets particularly in South Korea. FPD revenue ~~decreased~~increased by $16.50 million or 1.3.5% in YTD FY25 from YTD FY24, ~~primarily~~mainly ~~the~~due ~~result~~to ofincreased ~~lower~~mainstream demand in Asia.

Table of Contents

Gross Margin ($ in millions)

	Q2 FY25			Q1 FY25				Percent Change			Q2 FY24			Percent Change			YTD FY25			YTD FY24			Percent Change
							Percent						Percent									Percent
Gross profit	$	77.9		$	75.5			3.2	%	$	79.3			(1.8	)%		153.4			158.5			(3.2	)%
	Q3 FY25			Q2 FY25			Change			Q3 FY24			Change			YTD FY25			YTD FY24			Change
Gross margin		36.9	%		35.6	%					36.5	%					36.3	%		36.6	%
Gross profit	$	70.9		$	77.9			(9.0	)%	$	75.1			(5.6	)%		224.3			233.6			(4.0	)%
Gross margin		33.7	%		36.9	%					35.6	%					35.4	%		36.3	%

Gross margin ~~increased~~decreased by ~~132~~320 basis points in Q2Q3 FY25 as compared to Q1Q2 FY25, primarily as a result of ~~the~~an ~~decrease~~unfavorable inproduct ~~labor~~mix, ~~and~~reflected ~~benefits~~in material costs increase of 98.32%, or ~~103~~207 basis points as a percentage of revenue ~~and~~as ~~a decrease~~well as an increase in ~~equipment~~labor and ~~other~~benefits costs of ~~goods sold of 2~~6.3%, or 5170 basis points as a percentage of revenue.

Gross margin ~~increased~~decreased by 40190 basis points in Q2Q3 FY25, from Q2Q3 FY24, primarily as a result of ~~the~~an ~~decrease~~unfavorable inproduct ~~labor~~mix, ~~and~~reflected ~~benefits~~by material costs increase of 1011.84%, or 95278 basis points as a percentage of revenue, ~~and~~partially aoffset by a decrease in ~~material costs~~other cost of 1goods sold of 11.02%, or 44111 basis points as a percentage of revenue. ~~These favorable changes were partially offset by the unfavorable impact caused by the decrease in revenue of 2.8% from Q2 FY24.~~

Gross margin decreased by 3190 basis points in YTD FY25 as compared to YTD FY24, ~~primarily~~mainly asdue ato ~~result of~~ the decrease in revenue of 1.7% as well as an unfavorable product mix resulting in material costs increase by 2.45% or 102 basis points as a percentage of revenue, partially offset by decreased labor and benefits costs of 64.83%, or 5231 basis points as a percentage of revenue.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were $18.14 million in Q2Q3 FY25, compared with $1918.1 million in Q1Q2 FY25, and $19.04 million in Q2Q3 FY24. The $1.0.3 million ~~decrease~~increase from Q1Q2 FY25 was primarily the result of an ~~decreases~~ increase in ~~compensation and related expenses of $0.3 million and~~ professional fees of $0.32 million. The $01.90 million decrease from Q2Q3 FY24 was primarily the result of decreased ~~compensation~~professional ~~and~~fees ~~related expenses~~ of $0.8 million.

Selling, general and administrative expenses were $3755.26 million in YTD FY25, ~~remaining flat~~ compared with $3756.38 million in YTD FY24. The $1.2 million decrease from YTD FY24 was a result of a decrease in labor and benefits cost of $1.1 million.

Research and Development Expenses

Research and development expenses, which primarily consist of development and qualification efforts related to process technologies for high-end IC and FPD applications, were $4.13 million in Q2 Q3 FY25, compared with $4.31 million in Q1Q2 FY25, and $4.3.6 million in Q2Q3 FY24. The ~~decrease~~increase from Q1Q2 FY25 and Q3 FY24 was primarily caused by ~~reduced~~increased qualification activities in Asia.

Research and development expenses were $812.36 million in YTD FY25, compared with $711.73 million in YTD FY24. The $01.63 million increase from YTD FY24 was a result of increased development activities in the U.S.

Other Income (Expense), net ($ in millions)

	Q2 FY25			Q1 FY25			Q2 FY24			YTD FY25			YTD FY24
Foreign currency transactions impact, net	$	(31.1	)	$	18.4		$	14.8		$	(12.7	)	$	5.9
Interest expense		(0.0	)		(0.0	)		(0.1	)		(0.1	)		(0.2	)
Interest income and other income, net		5.3			6.6			5.8			12.0			11.1
Other income (expense), net	$	(25.8	)	$	25.0		$	20.5		$	(0.8	)	$	16.8

Other Income (expense) decreased in Q2 FY25 from Q1 FY25 by $50.8 million and from Q2 FY24 by $46.3 million, primarily due to foreign currency impacts. The foreign currency impacts were primarily driven by unfavorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar.

Table of Contents

Other Income (~~expense~~Expense), ~~decreased~~net ~~in YTD FY25 from YTD FY24 by~~ ($~~17.6~~ ~~million,~~in primarily due to foreign currency impacts. The foreign currency impacts were primarily driven by unfavorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar.millions)

	Q3 FY25			Q2 FY25			Q3 FY24			YTD FY25			YTD FY24
Foreign currency transactions impact, net	$	(14.3	)	$	(31.1	)	$	4.1		$	(26.9	)	$	9.9
Interest expense		-			-			(0.1	)		(0.1	)		(0.3	)
Interest income and other income, net		4.8			5.3			6.1			16.8			17.3

Other income (expense), net	$	(9.4	)	$	(25.8	)	$	10.1		$	(10.2	)	$	26.9

* The columns may not foot due to rounding.

Other Expense, net decreased in Q3 FY25 from Q2 FY25 by $16.4 million primarily driven by favorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar. Other Expense, net increased in Q3 FY25 from Q3 FY24 by $19.5 million primarily driven by unfavorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar.

Other Expense, net increased in YTD FY25 from YTD FY24 by $37.1 million, primarily due to foreign currency impacts which were driven by unfavorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar.

Income Tax Provision ($ in millions)

	Q2 FY25			Q1 FY25			Q2 FY24			YTD FY25			YTD FY24
	Q3 FY25			Q2 FY25			Q3 FY24			YTD FY25			YTD FY24
Income tax provision	$	59.76		$	185.97		$	2014.21		$	2434.62		$	3449.90
Effective income tax rate		1924.18	%		2419.51	%		2622.47	%		23.05	%		2625.84	%

On December 15, 2022, the European Union (EU) Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a minimum effective tax rate of 15%, as established by the Organization for Economic Co-operation and Development (OECD) Pillar Two Framework. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. A significant number of other countries are expected to also implement similar legislation with varying effective dates. The Company is currently subject to Pillar Two, but we estimate that the financial impact is immaterial. We will ~~continuously~~continue ~~evaluate~~to ~~the~~monitor ~~potential~~further ~~impact~~developments ofto ~~the~~determine ~~Pillar~~any ~~Two~~potential ~~Framework~~impact ~~to ensure~~in wethe ~~are~~countries ~~compliant~~ in ~~the~~which ~~future~~we operate.

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the United States. The OBBBA includes significant changes to federal tax law and other regulatory provisions that may impact the Company. The legislation enacted will be effective for Photronics commencing in our fiscal year 2026. We will continue to monitor and evaluate the impact of the legislative changes as more guidance becomes available.

The effective income tax rate is sensitive to the jurisdictional mix of earnings, due in part to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances where the tax benefits of the losses are not available.

The effective income tax rate ~~decrease~~increases in Q2Q3 FY25, compared with Q1Q2 FY25 and ~~with~~Q3 Q2 FY24, isare primarily due to ~~a decrease in foreign taxes as well as~~ changes in the jurisdictional mix of earnings.

The effective income tax rate decrease in YTD FY25 compared with YTD FY24, is primarily due to ~~a decrease in foreign taxes as well as~~ changes in the jurisdictional mix of earnings.

Net Income Attributable to Noncontrolling Interests

Net income attributable to noncontrolling interests was $15.4 million in Q2 FY25, compared with $15.4 million in Q1 FY25 and $20.1 million in Q2 FY24; the decrease year over year was the result of a net decrease in the net income of the Company’s joint venture operations. Net income attributable to noncontrolling interests was $30.8 million in YTD FY25, compared with $33.0 million in YTD FY24. The decrease was a result of decreased net income at the Company’s joint-venture operations.

Liquidity and Capital Resources

Cash and cash equivalents were $530.7 million and $598.5 million as of May 4, 2025, and October 31, 2024, respectively. As of May 4, 2025, total cash and cash equivalents included $431.9 million held by foreign subsidiaries, including an aggregate of $349.9 million held by our joint ventures in Taiwan and China. In addition, we currently have CNY 200 million (approximately $27.5 million) of borrowing capacity in China to support local operations. See Note 7 – Debt to the consolidated financial statements for additional information on the Company’s outstanding debt and currently available financing. The Company’s primary sources of liquidity are the Company’s cash on hand and cash we generate from operations.

We continually evaluate alternatives for efficiently funding the Company’s capital expenditures and ongoing operations. These reviews may result in the Company’s engagement in a variety of investing and financing transactions, in the transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to foreign withholding taxes; in certain jurisdictions, repatriation of these funds to the U.S. may subject them to U.S. state income taxes and/or local country withholding taxes. We believe that the Company’s liquidity, including available financing, is sufficient to meet the Company’s requirements through the next twelve months and thereafter for the foreseeable future. Through the utilization of the Company’s existing liquidity, cash we generate from operations and short-term investments, we plan to continue to invest in the Company’s business, with the Company’s investments targeted to align with the Company’s customers’ technology road maps. In addition, we stand ready to invest in mergers, acquisitions, or strategic partnerships, should a suitable opportunity arise.

Table of Contents

WeNet ~~estimate~~Income ~~capital~~Attributable expenditures for the Company’s fiscal year 2025 will be approximately $200 million mainly in Asia and the U.S.; these investments will be targeted towards high-end and mainstream capacity that will increase the Company’s operating capability and efficiency and enable us to ~~support~~Noncontrolling customers’ near-term demands. As of May 4, 2025, we had outstanding capital commitments of approximately $164.8 million and accrued liabilities related to capital equipment purchases of approximately $14.5 million. Although payment timing could vary, primarily as a result of the timing of tool delivery, installation and testing, we currently estimate that we will fund $152.3 million of the Company’s total $179.3 million committed and recognized obligations for capital expenditures over the next twelve months.Interests

OnNet ~~August~~income ~~28,~~attributable ~~2024,~~to ~~the~~noncontrolling ~~Board~~interests ofwas ~~Directors~~$6.2 ~~authorized~~million anin ~~increase~~Q3 toFY25, ~~the~~compared ~~Company’s~~with ~~existing~~$15.4 ~~share~~million ~~repurchase~~in ~~program~~Q2 ~~from~~FY25 ~~the~~and ~~remaining~~ $3113.78 million toin ~~$100~~Q3 ~~million.~~FY24; ~~During~~ the ~~six-month~~decrease ~~period~~from ~~ended~~Q2 ~~May~~FY25 ~~4, 2025,~~and Q3 FY24 was the ~~Company~~result ~~repurchased~~of ~~3.8~~the ~~million~~decrease ~~shares~~in ~~for~~net ~~$76.7~~income ~~million~~of the Company’s joint ventures. AsNet ofincome ~~May~~attributable 4,to ~~2025,~~noncontrolling ~~there~~interests was $2337.30 million ~~remaining~~in ~~under~~YTD ~~the August 28~~FY25, ~~2024~~compared ~~authorization~~with $46.8 ~~Depending~~million onin ~~market~~YTD ~~conditions,~~FY24. weThe ~~may~~decrease ~~utilize~~was ~~some~~a orresult ~~the~~of ~~entire~~decreased ~~remaining approved~~net ~~amount~~income toat ~~reacquire~~the ~~additional~~Company’s ~~shares~~joint-venture operations.

AsLiquidity discussed in Note 6 – PDMCX Joint Venture of the Company’s consolidated financial statements, DNP, the noncontrolling interest in the Company’s China-based joint venture has, under certain circumstances, the right to put its interest in the joint venture to Photronics, or to purchase the Company’s interest in the joint venture. Under all such circumstances, the sale of DNP’s interest would be at its ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and ~~clearance.~~Capital As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. As of May 4, 2025, Photronics and DNP each had net investments in this joint venture of approximately $148.5 million.Resources

Cash ~~Flows~~and cash equivalents were $479.5 million and $598.5 million as of August 3, 2025, and October 31, 2024, respectively. As of August 3, 2025, total cash and cash equivalents included $416.1 million held by foreign subsidiaries, including an aggregate of $328.2 million held by our joint ventures in Taiwan and China. In addition, we currently have CNY 200 million or USD 25 million of borrowing capacity in China to support local operations. See Note 7 – Debt to the consolidated financial statements for additional information on the Company’s outstanding debt and currently available financing. The Company’s primary sources of liquidity are the Company’s cash on hand and cash we generate from operations.

	YTD FY25			YTD FY24
Net cash provided by operating activities	$	109.9		$	118.0
Net cash used in investing activities	$	(80.8	)	$	(114.7	)
Net cash used in financing activities	$	(95.1	)	$	(4.7	)

We continually evaluate alternatives for efficiently funding the Company’s capital expenditures and ongoing operations. These reviews may result in the Company’s engagement in a variety of investing and financing transactions, in the transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to foreign withholding taxes; in certain jurisdictions, repatriation of these funds to the U.S. may subject them to U.S. state income taxes and/or local country withholding taxes. We believe that the Company’s liquidity, including available financing, is sufficient to meet the Company’s requirements through the next twelve months and thereafter for the foreseeable future. Through the utilization of the Company’s existing liquidity, the cash we generate from operations and short-term investments, we plan to continue to invest in the Company’s business, with the Company’s investments targeted to align with the Company’s customers’ technology road maps. In addition, we stand ready to invest in mergers, acquisitions, or strategic partnerships, should a suitable opportunity arise.

~~Operating~~We ~~Activities:~~estimate ~~Net~~capital ~~cash~~expenditures ~~provided~~for bythe ~~operating~~Company’s ~~activities~~fiscal ~~reflects~~year ~~net~~2025 ~~income~~will ~~adjusted~~be ~~for~~approximately ~~certain~~$200 ~~non-cash~~million ~~items,~~mainly ~~including~~in ~~depreciation~~Asia and ~~amortization, share~~the U.S.; these investments will be targeted towards high-~~based~~end ~~compensation~~and mainstream capacity that will increase the Company’s operating capability and efficiency, and ~~the~~enable ~~effects~~us to support customers’ near-term demands. As of ~~changes~~August in3, ~~operating~~2025, ~~assets~~we ~~and~~had ~~liabilities~~outstanding capital commitments of approximately $147.2 ~~Net~~million ~~cash~~and ~~provided~~accrued byliabilities ~~operating~~related ~~activities~~to ~~decreased~~capital byequipment purchases of approximately $828.13 million. inAlthough ~~FY25~~payment timing could vary, ~~compared~~primarily ~~with~~as ~~the~~a ~~same~~result ~~period~~of the timing of ~~FY24~~tool delivery, ~~primarily~~installation ~~due~~and totesting, ~~decreased~~we ~~net~~currently estimate that we will fund $154.8 million of the Company’s total $175.5 ~~income~~ million committed and recognized obligations for capital expenditures over the next twelve months.

~~Investing~~On ~~Activities: Net~~August ~~cash~~28, ~~flows~~2024, ~~used~~the inBoard ~~investing~~of ~~activities~~Directors ~~decreased~~authorized byan ~~$33.9~~increase ~~million~~to inthe ~~FY25,~~Company’s ~~compared~~existing toshare repurchase program from the ~~cash~~ ~~flows~~remaining ~~used~~$31.7 inmillion ~~investing~~to ~~activities~~$100 inmillion. During the ~~same~~nine-month period ofended ~~FY24~~August 3, ~~primarily~~2025, ~~driven~~the byCompany anrepurchased ~~increase~~5 million inshares ~~proceeds~~for ~~from~~$97.4 ~~short-term~~million. ~~investments~~In June 2025, the Board of Directors authorized an additional $~~28.3~~25 million ~~and~~share arepurchase. ~~decrease~~As ofa ~~purchases~~result, as of ~~short~~August ~~term~~3, ~~investments~~2025, of $3827.36 million, ~~partially offset~~remained byavailable anunder ~~increase~~this ofauthorization. ~~purchases~~Depending ofon ~~property~~market conditions, ~~plant~~we ~~and~~may ~~equipment~~utilize ofsome ~~$32.4~~or ~~million~~the entire remaining approved amount to reacquire additional shares.

~~Financing~~As ~~Activities:~~discussed ~~Net~~in ~~cash~~Note ~~used~~6 – PDMCX Joint Venture of the Company’s consolidated financial statements, DNP, the noncontrolling interest in ~~financing~~the ~~activities~~Company’s ~~increased~~China-based byjoint ~~$90.4~~venture has, ~~million~~under certain circumstances, the right to put its interest in the ~~first~~joint ~~half~~venture ofto ~~FY25~~Photronics, ~~compared~~or to purchase the ~~same~~Company’s ~~period~~interest ofin ~~FY24~~the joint venture. ~~This~~Under ~~was primarily~~all ~~driven~~such bycircumstances, the ~~repurchase~~sale of DNP’s interest would be at its ownership percentage of the ~~Company~~joint venture’s ~~common~~net ~~shares~~book asvalue, ~~part~~with closing to take place within three business days of obtaining required approvals and clearance. As of the ~~Share~~date ~~Repurchase~~of ~~Program~~issuance of ~~$76~~this report, DNP had not indicated its intention to exercise this right.7 ~~million~~As of August 3, 2025, Photronics and ~~increase~~DNP ofeach ~~debt~~had ~~repayments~~net investments in this joint venture of approximately $15153.24 million.

Effects of exchange rate changes on the Company’s cash, cash equivalents, and restricted cash balances decreased by $2.1 million from unfavorable $3.8 million during the first half of FY24 to unfavorable $1.7 million during the same period of FY25.

Table of Contents

Cash Flows

	YTD FY25			YTD FY24
Net cash provided by operating activities	$	160.0		$	193.1
Net cash used in investing activities	$	(173.6	)	$	(142.1	)
Net cash used in financing activities	$	(115.3	)	$	(6.4	)

Operating Activities: Net cash provided by operating activities reflects net income adjusted for certain non-cash items, including depreciation and amortization, share-based compensation, and the effects of changes in operating assets and liabilities. Net cash provided by operating activities decreased by $33.1 million in FY25, compared with the same period of FY24, primarily due to decreased net income.

Investing Activities: Net cash flows used in investing activities increased by $31.5 million in FY25, compared to the same period in FY24, primarily driven by an increase of purchases of property, plant and equipment of $32.9 million partially offset by a decrease in purchases of short term investments of $4.0 million.

Financing Activities: Net cash used in financing activities increased by $108.9 million in FY25, compared to the same period of FY24. This was primarily driven by the repurchase of the Company’s common shares as part of the Share Repurchase Program of $97.4 million and increase of debt repayments of $13.5 million.

Effects of exchange rate changes on the Company’s cash, cash equivalents, and restricted cash balances increased by $16.6 million from unfavorable $6.5 million during YTD FY24 to favorable $10.1 million during the same period of FY25.

Non-GAAP Financial Measures

Non-GAAP Net Income attributable to Photronics, Inc. shareholders and non-GAAP diluted earnings per share ~~are~~attributable ~~considered~~to asPhotronics, Inc. shareholders are “non-GAAP financial measures” as such term is defined by Regulation G of the ~~Securities~~ Securities and Exchange Commission and may differ from similarly named non-GAAP financial measures used by other companies. The financial tables below reconcile Photronics, Inc. financial results under U.S. GAAP to our non-GAAP financial information. We believe these non-GAAP financial measures that exclude certain items are useful for analysts and investors to evaluate the Company’s on-going performance because they enable a more meaningful comparison of historical results of the Company’s core business. These non-GAAP metrics are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss), Net income (loss) per share, or any other measure of ~~consolidated~~ consolidated results under U.S. GAAP. The items excluded from these non-GAAP metrics but included in the calculation of their closest U.S. GAAP equivalent, are significant components of the condensed consolidated statement of income and must be ~~considered~~ considered in performing a comprehensive assessment of overall financial performance.

The following table reconciles U.S. GAAP to Non-GAAP Income for the indicated periods. The columns may not foot due to rounding.

	Three Months Ended
	May 4, 2025			February 2, 2025			April 28, 2024
Reconciliation of U.S. GAAP to Non-GAAP Net Income:
U.S. GAAP Net Income attributable to Photronics, Inc. shareholders	$	8,861		$	42,851		$	36,251
FX loss (gain)		31,111			(18,443	)		(14,766	)
Estimated tax effects of above		(8,337	)		5,152			3,743
Estimated noncontrolling interest effects of above		(7,376	)		2,823			3,489
Non-GAAP Net Income attributable to Photronics, Inc. shareholders	$	24,259		$	32,383		$	28,717
Weighted-average number of common shares outstanding - Diluted		60,974			62,661			62,409
Reconciliation of U.S. GAAP to Non-GAAP EPS:
U.S. GAAP diluted earnings per share	$	0.15		$	0.68		$	0.58
Effects of the above non-GAAP adjustments		0.25			(0.16	)		(0.12	)
Non-GAAP diluted earnings per share	$	0.40		$	0.52		$	0.46

Business Outlook

Our current business outlook and guidance was provided in the Photronics Q2 FY25 earnings press release, earnings presentation, and financial results conference call, but is not incorporated herein. These can be accessed in the investor section of our website - www.photronics.com. Information included on our website is not incorporated in this Form 10-Q.

Our future results of operations and the other forward-looking statements contained in this filing and in the Photronics Q2 FY25 earnings press release, and the related financial results conference call and earnings presentation involve a number of risks and uncertainties, some of which were discussed in Part I, Item 1A of our 2024 Form 10-K. These factors and a number of other unforeseeable factors could cause actual results to differ materially from our expectations.

Table of Contents

The following table reconciles U.S. GAAP Net Income and Earnings per Share attributable to Photronics, Inc. shareholders to the Non-GAAP Net income and Earnings per Share attributable to Photronics, Inc. shareholders for the indicated periods. The columns may not foot due to rounding.

	Three Months Ended
	August 3,			May 4,			July 28,
	2025			2025			2024
U.S. GAAP Net Income attributable to Photronics, Inc. shareholders	$	22,891		$	8,861		$	34,388
FX (gain) loss		14,258			31,111			(4,068	)
Estimated tax effects of above		(3,663	)		(8,337	)		914
Estimated noncontrolling interest effects of above		(4,130	)		(7,376	)		681
Non-GAAP Net Income attributable to Photronics, Inc. shareholders	$	29,356		$	24,259		$	31,915

Weighted-average number of common shares outstanding - Diluted		58,068			60,974			62,414

U.S. GAAP diluted earnings per share attributable to Photronics, Inc. shareholders	$	0.39		$	0.15		$	0.55
Effects of the above non-GAAP adjustments		0.12			0.25			(0.04	)
Non-GAAP diluted earnings per share attributable to Photronics, Inc. shareholders	$	0.51		$	0.40		$	0.51

Business Outlook

Our current business outlook and guidance was provided in the Photronics Q3 FY25 earnings press release, earnings presentation, and financial results conference call, but is not incorporated herein. These can be accessed in the investor section of our website - www.photronics.com. Information included on our website is not incorporated in this Form 10-Q.

Our future results of operations and the other forward-looking statements contained in this filing and in the Photronics Q3 FY25 earnings press release, and the related financial results conference call and earnings presentation involve a number of risks and uncertainties, some of which were discussed in Part I, Item 1A of our 2024 Form 10-K. These factors and a number of other unforeseeable factors could cause actual results to differ materially from our expectations.

Critical Accounting Estimates

Please refer to Part II, Item 7 of our 2024 Form 10-K for discussion of our critical accounting estimates. There have been no changes to our critical accounting estimates since the filing of our Form 10-K for the year ended October 31, 2024.

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Currency Exchange Rate Risk

We conduct business in several major currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese yuan, and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we engage in transactions and have exposures to the Japanese yen.

Table of Contents

We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell products in a currency other than the functional currency of the entity where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing entity. We may also enter into derivative contracts to mitigate our exposure to foreign currency fluctuations when we have a significant purchase obligation or significant receivable denominated in a currency that differs from the functional currency of the transacting subsidiary. We do not enter into derivatives for speculative purposes. There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.

Our primary net foreign currency exposures as of ~~May~~August 43, 2025, included the South Korean won, the Japanese yen, the New Taiwan dollar, the Chinese yuan, the Singapore dollar, the British pound sterling, and the euro. As of that date, a 10% adverse movement in the value of currencies different from the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $7169.37 million, which represents ana ~~increase~~decrease of $81.6 million from our exposure at ~~February~~May 24, 2025. Our most significant exposures at ~~May~~August 43, 2025, were exposures of the ~~South~~New ~~Korean~~Taiwan ~~won~~dollar, the ~~Chinese~~South ~~yuan,~~Korean won and the ~~New~~Chinese ~~Taiwan~~yuan ~~dollar~~ to the U.S. dollar, which were, respectively, $2536.31 million, $824.6 9 million, and $345.4 million at that date. We do not believe that a 10% change in the exchange rates of non-US dollar currencies, other than the aforementioned currencies and the Japanese yen, would have had a material effect on our ~~May~~August 43, 2025, condensed consolidated financial statements.

Interest Rate Risk

A 10% adverse or favorable movement in the interest rates on our variable rate borrowings would not have had a material effect on the Company’s ~~May~~August 43, 2025, condensed consolidated financial statements, as there were no variable rate borrowings outstanding as of the balance sheet date.

Item 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We have established, and currently maintain, disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms, and that such information is ~~accumulated~~ accumulated and communicated to management, including our ~~chief~~Chief ~~executive~~Executive ~~officer~~Officer and ~~chief~~Chief ~~financial~~Financial ~~officer~~Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management ~~necessarily~~ was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

33 Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

Table of Contents

Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting during the ~~second~~third fiscal quarter ended ~~May~~August 43, 2025, ~~that~~which have materially affected, or are reasonably likely to to materially affect, the Company’s internal control over financial reporting.

Table of Contents

PART II.

OTHER INFORMATION

Item 1.

LEGAL PROCEEDINGS

Please refer to Note 12 within Part I, Item 1 of this report for information on legal proceedings involving the Company.

Item 1A.

RISK FACTORS

There have been no material changes, except the paragraph below, to our risk factors as set forth in “Item 1A. Risk Factors” in our 2024 Form 10-K.

Risks Related to Tariffs and Global Trade Policies

In ~~the second quarter of~~ FY25, new tariffs were announced on imports to the U.S., ~~including additional tariffs on imports from China, Taiwan, South Korea, Japan and the European Union, among others,~~ followed by various modifications and delays. ~~In response, several countries have imposed, or threatened to impose, reciprocal tariffs on imports from the U.S. and other retaliatory measures.~~ Further changes are expected to be made in the future, which may include additional sector-based tariffs or other measures. The U.S. Department of Commerce has initiated an investigation under Section 232 of the Trade Expansion Act of 1962, as amended, into, among other things, imports of semiconductors, semiconductor manufacturing equipment, and their derivative products, including downstream products that contain semiconductors. Tariffs and trade restrictions may increase costs and complexity in our supply chain, including the procurement of semiconductor manufacturing equipment, raw materials, and critical components. They may also elevate the cost of our products, reduce demand, and negatively affect customer purchasing behavior. These risks, individually or collectively, could ~~have~~adversely aaffect ~~material adverse effect on~~ our business, financial condition, and results of operations.

Item 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

In September 2020, the Company’s Board of Directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b-18 of the Exchange Act. The repurchase authorization by the Board of Directors has no expiration date, does not obligate usthe Company to acquire any common stock, and is subject to market conditions. From September 2020 through October 2022, the Company repurchased 5.8 million shares at a cost of $68.3 million. No shares were repurchased during the three- or nine-month periods ended July 28, 2024. In August 2024, the Board of Directors authorized an increase to the Company’s existing share repurchase program from the remaining $31.7 million up to $100 million. During the ~~six~~three-month period ended ~~May~~August 43, 2025, the Company repurchased 31.82 million shares at a cost of $7620.7 million pursuant to Rule 10b-18 of the Exchange Act. During the nine-month period ended August 3, 2025, the Company repurchased 5 million shares at a cost of $97.4 million pursuant to Rule 10b-18 of the Exchange Act. In June 2025, the Board of Directors authorized an additional $25 million share repurchase. As a result, as of ~~May~~August 43, 2025, $2327.36 million remained available under this authorization. All ~~for~~shares repurchased under the ~~repurchase~~program ofhave ~~additional~~been ~~shares~~retired.

3435

Table of Contents

The following table provides information relating to the Company’s repurchase of common stock during the ~~second~~third quarter of fiscal year 2025. This table excludes shares repurchased to settle employee tax withholding related to the vesting of stock awards.

	Total Number of Shares Purchased		Average Price Paid Per share		Total Number of Shares Purchased as Part of Publicly Announced Program		Dollar Value of Shares That May Yet Be Purchased (in millions)
February 3, 2025 – March 2, 2025		-	$	-		-	$	95.4
May 5, 2025 – June 1, 2025		366,900	$	17.34		366,900	$	16.9
March 3, 2025 – March 30, 2025		2,262,912	$	21.09		2,262,912	$	47.6
June 2, 2025 – June 29, 2025		810,630	$	17.72		810,630	$	27.6
March 31, 2025 – May 4, 2025		1,352,287	$	17.99		1,352,287	$	23.3
June 30, 2025 – August 3, 2025		-	$	-		-	$	27.6
Total		31,~~615~~177,~~199~~530				31,~~615~~177,~~199~~530

Item 3.

DEFAULTS UPON SENIOR SECURITIES

None.

Item 4.

MINE SAFETY DISCLOSURES

Not applicable

Item 5.

OTHER INFORMATION

Rule 10b5-1 Trading Arrangements

Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act.

No such plans or arrangements were adopted or terminated, including by modification, by any director or officer (as defined in Rule 16a-1 under the Exchange Act) during the quarter ended ~~May~~August 43, 2025.

~~Director Indemnification Agreements~~36

On June 9, 2025, the Company entered into customary indemnification agreements with each of its directors. These agreements require the Company to provide indemnification and expense reimbursement to the director for losses incurred in legal proceedings related to his or her service as Company director in certain circumstances and to advance funds to the director to pay expenses as they are incurred.

Table of Contents

Item 6.

EXHIBITS

		~~Incorporated by Reference~~	Incorporated by Reference
Exhibit Number	Description	~~Form~~	~~Exhibit~~Form	~~Filing Date~~Exhibit	~~Filed~~Filing ~~or Furnished Herewith~~Date	Filed or Furnished Herewith
10.1	Form of Director Indemnification Agreement				X
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					X
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.					X
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.				X
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					X
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.					X
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.				X
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)					X
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)				X
101.SCH	Inline XBRL Taxonomy Extension Schema Document					X
101.SCH	Inline XBRL Taxonomy Extension Schema Document				X
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document					X
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document				X
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document					X
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document				X
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document					X
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document				X
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document					X
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document				X
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)					X
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)				X

3637

Table of Contents

SIGNATURES

Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Photronics, Inc. (Registrant) By: /s/ ERIC RIVERA ERIC RIVERA Executive Vice President, Chief Financial Officer (Principal Financial Officer /Principal Accounting Officer)

	Photronics, Inc.
	(Registrant)

By:	/s/ ERIC RIVERA
	ERIC RIVERA
	Executive Vice President,
	Chief Financial Officer
	(Principal Financial Officer
	/Principal Accounting Officer)

Date: September 9, 2025

~~Date: June 11, 2025~~ 38

P7D P14D P14D P21D 0000810136 false Q3 --10-31 P1Y321D 0000810136 2024-11-01 2025-08-03 0000810136 2025-09-04 0000810136 2025-08-03 0000810136 2024-10-31 0000810136 2025-05-05 2025-08-03 0000810136 2024-04-29 2024-07-28 0000810136 2023-11-01 2024-07-28 0000810136 us-gaap:CommonStockMember 2025-05-04 0000810136 us-gaap:AdditionalPaidInCapitalMember 2025-05-04 0000810136 us-gaap:RetainedEarningsMember 2025-05-04 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-05-04 0000810136 us-gaap:NoncontrollingInterestMember 2025-05-04 0000810136 2025-05-04 0000810136 us-gaap:CommonStockMember 2025-05-05 2025-08-03 0000810136 us-gaap:AdditionalPaidInCapitalMember 2025-05-05 2025-08-03 0000810136 us-gaap:RetainedEarningsMember 2025-05-05 2025-08-03 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-05-05 2025-08-03 0000810136 us-gaap:NoncontrollingInterestMember 2025-05-05 2025-08-03 0000810136 us-gaap:CommonStockMember 2025-08-03 0000810136 us-gaap:AdditionalPaidInCapitalMember 2025-08-03 0000810136 us-gaap:RetainedEarningsMember 2025-08-03 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-08-03 0000810136 us-gaap:NoncontrollingInterestMember 2025-08-03 0000810136 us-gaap:CommonStockMember 2024-04-28 0000810136 us-gaap:AdditionalPaidInCapitalMember 2024-04-28 0000810136 us-gaap:RetainedEarningsMember 2024-04-28 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-28 0000810136 us-gaap:NoncontrollingInterestMember 2024-04-28 0000810136 2024-04-28 0000810136 us-gaap:CommonStockMember 2024-04-29 2024-07-28 0000810136 us-gaap:AdditionalPaidInCapitalMember 2024-04-29 2024-07-28 0000810136 us-gaap:RetainedEarningsMember 2024-04-29 2024-07-28 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-29 2024-07-28 0000810136 us-gaap:NoncontrollingInterestMember 2024-04-29 2024-07-28 0000810136 us-gaap:CommonStockMember 2024-07-28 0000810136 us-gaap:AdditionalPaidInCapitalMember 2024-07-28 0000810136 us-gaap:RetainedEarningsMember 2024-07-28 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-28 0000810136 us-gaap:NoncontrollingInterestMember 2024-07-28 0000810136 2024-07-28 0000810136 us-gaap:CommonStockMember 2024-10-31 0000810136 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0000810136 us-gaap:RetainedEarningsMember 2024-10-31 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-31 0000810136 us-gaap:NoncontrollingInterestMember 2024-10-31 0000810136 us-gaap:CommonStockMember 2024-11-01 2025-08-03 0000810136 us-gaap:AdditionalPaidInCapitalMember 2024-11-01 2025-08-03 0000810136 us-gaap:RetainedEarningsMember 2024-11-01 2025-08-03 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-11-01 2025-08-03 0000810136 us-gaap:NoncontrollingInterestMember 2024-11-01 2025-08-03 0000810136 us-gaap:CommonStockMember 2023-10-31 0000810136 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0000810136 us-gaap:RetainedEarningsMember 2023-10-31 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-10-31 0000810136 us-gaap:NoncontrollingInterestMember 2023-10-31 0000810136 2023-10-31 0000810136 us-gaap:CommonStockMember 2023-11-01 2024-07-28 0000810136 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-07-28 0000810136 us-gaap:RetainedEarningsMember 2023-11-01 2024-07-28 0000810136 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-11-01 2024-07-28 0000810136 us-gaap:NoncontrollingInterestMember 2023-11-01 2024-07-28 0000810136 country:TW 2024-11-01 2025-08-03 0000810136 country:KR 2024-11-01 2025-08-03 0000810136 country:CN 2024-11-01 2025-08-03 0000810136 country:US 2024-11-01 2025-08-03 0000810136 srt:EuropeMember 2024-11-01 2025-08-03 0000810136 us-gaap:CashMember 2025-08-03 0000810136 us-gaap:CashMember 2024-10-31 0000810136 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member 2025-08-03 0000810136 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member 2024-10-31 0000810136 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2025-08-03 0000810136 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2024-10-31 0000810136 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2025-08-03 0000810136 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member 2024-10-31 0000810136 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel2Member 2025-08-03 0000810136 us-gaap:BankTimeDepositsMember us-gaap:FairValueInputsLevel2Member 2024-10-31 0000810136 us-gaap:LandMember 2025-08-03 0000810136 us-gaap:LandMember 2024-10-31 0000810136 us-gaap:BuildingAndBuildingImprovementsMember 2025-08-03 0000810136 us-gaap:BuildingAndBuildingImprovementsMember 2024-10-31 0000810136 us-gaap:MachineryAndEquipmentMember 2025-08-03 0000810136 us-gaap:MachineryAndEquipmentMember 2024-10-31 0000810136 us-gaap:LeaseholdImprovementsMember 2025-08-03 0000810136 us-gaap:LeaseholdImprovementsMember 2024-10-31 0000810136 us-gaap:FurnitureAndFixturesMember 2025-08-03 0000810136 us-gaap:FurnitureAndFixturesMember 2024-10-31 0000810136 us-gaap:ConstructionInProgressMember 2025-08-03 0000810136 us-gaap:ConstructionInProgressMember 2024-10-31 0000810136 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2018-01-01 2018-01-31 0000810136 plab:PhotronicsAndDNPMember srt:MinimumMember 2024-11-01 2025-08-03 0000810136 plab:PhotronicsAndDNPMember 2024-11-01 2025-08-03 0000810136 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-11-01 2025-08-03 0000810136 plab:PhotronicsAndDNPMember 2025-05-05 2025-08-03 0000810136 plab:PhotronicsAndDNPMember 2024-04-29 2024-07-28 0000810136 plab:PhotronicsAndDNPMember 2023-11-01 2024-07-28 0000810136 plab:PDMCXMember 2025-08-03 0000810136 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-08-03 0000810136 plab:PDMCXMember 2024-10-31 0000810136 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-10-31 0000810136 plab:Seven2MillionFinanceLeaseMember 2025-08-03 0000810136 plab:Seven2MillionFinanceLeaseMember 2021-02-28 0000810136 plab:Seven2MillionFinanceLeaseMember plab:MonthlyMember 2021-02-01 2021-02-28 0000810136 plab:Three55MillionFinanceLeaseMember 2025-08-03 0000810136 plab:Three55MillionFinanceLeaseMember 2020-12-31 0000810136 plab:Three55MillionFinanceLeaseMember plab:FirstThreeMonthsMember 2021-01-01 2021-01-31 0000810136 plab:Three55MillionFinanceLeaseMember plab:FollowingNineMonthsMember 2021-01-01 2021-01-31 0000810136 plab:Three55MillionFinanceLeaseMember plab:FollowedByThirtySixMonthsMember 2021-01-01 2021-01-31 0000810136 plab:Three55MillionFinanceLeaseMember 2021-01-31 0000810136 plab:WorkingCapitalLoanMember 2018-11-30 0000810136 plab:WorkingCapitalLoanMember 2022-12-01 2022-12-31 0000810136 plab:WorkingCapitalLoanMember 2025-07-31 0000810136 plab:WorkingCapitalLoanMember 2024-11-01 2025-08-03 0000810136 plab:WorkingCapitalLoanMember 2025-08-03 0000810136 plab:FinanceLeaseMember 2025-08-03 0000810136 plab:FinanceLeaseMember 2024-10-31 0000810136 plab:FinanceLeaseMember 2024-11-01 2025-08-03 0000810136 plab:FinanceLeaseMember 2024-02-01 2024-10-31 0000810136 srt:MinimumMember 2024-11-01 2025-08-03 0000810136 srt:MaximumMember 2024-11-01 2025-08-03 0000810136 plab:IntegratedCircuitsMember srt:MinimumMember 2024-11-01 2025-08-03 0000810136 plab:IntegratedCircuitsMember srt:MaximumMember 2024-11-01 2025-08-03 0000810136 plab:FlatPanelDisplaysMember srt:MinimumMember 2024-11-01 2025-08-03 0000810136 plab:FlatPanelDisplaysMember srt:MaximumMember 2024-11-01 2025-08-03 0000810136 us-gaap:OtherCurrentAssetsMember 2025-08-03 0000810136 us-gaap:OtherCurrentAssetsMember 2024-10-31 0000810136 plab:AccruedLiabilitiesCurrentMember 2025-08-03 0000810136 plab:AccruedLiabilitiesCurrentMember 2024-10-31 0000810136 us-gaap:OtherNoncurrentLiabilitiesMember 2025-08-03 0000810136 us-gaap:OtherNoncurrentLiabilitiesMember 2024-10-31 0000810136 plab:HighEndIntegratedCircuitsMember 2025-05-05 2025-08-03 0000810136 plab:HighEndIntegratedCircuitsMember 2024-04-29 2024-07-28 0000810136 plab:HighEndIntegratedCircuitsMember 2024-11-01 2025-08-03 0000810136 plab:HighEndIntegratedCircuitsMember 2023-11-01 2024-07-28 0000810136 plab:MainstreamIntegratedCircuitsMember 2025-05-05 2025-08-03 0000810136 plab:MainstreamIntegratedCircuitsMember 2024-04-29 2024-07-28 0000810136 plab:MainstreamIntegratedCircuitsMember 2024-11-01 2025-08-03 0000810136 plab:MainstreamIntegratedCircuitsMember 2023-11-01 2024-07-28 0000810136 plab:IntegratedCircuitsMember 2025-05-05 2025-08-03 0000810136 plab:IntegratedCircuitsMember 2024-04-29 2024-07-28 0000810136 plab:IntegratedCircuitsMember 2024-11-01 2025-08-03 0000810136 plab:IntegratedCircuitsMember 2023-11-01 2024-07-28 0000810136 plab:HighEndFlatPanelDisplaysMember 2025-05-05 2025-08-03 0000810136 plab:HighEndFlatPanelDisplaysMember 2024-04-29 2024-07-28 0000810136 plab:HighEndFlatPanelDisplaysMember 2024-11-01 2025-08-03 0000810136 plab:HighEndFlatPanelDisplaysMember 2023-11-01 2024-07-28 0000810136 plab:MainstreamFlatPanelDisplaysMember 2025-05-05 2025-08-03 0000810136 plab:MainstreamFlatPanelDisplaysMember 2024-04-29 2024-07-28 0000810136 plab:MainstreamFlatPanelDisplaysMember 2024-11-01 2025-08-03 0000810136 plab:MainstreamFlatPanelDisplaysMember 2023-11-01 2024-07-28 0000810136 plab:FlatPanelDisplaysMember 2025-05-05 2025-08-03 0000810136 plab:FlatPanelDisplaysMember 2024-04-29 2024-07-28 0000810136 plab:FlatPanelDisplaysMember 2024-11-01 2025-08-03 0000810136 plab:FlatPanelDisplaysMember 2023-11-01 2024-07-28 0000810136 country:TW 2025-05-05 2025-08-03 0000810136 country:TW 2024-04-29 2024-07-28 0000810136 country:TW 2023-11-01 2024-07-28 0000810136 country:CN 2025-05-05 2025-08-03 0000810136 country:CN 2024-04-29 2024-07-28 0000810136 country:CN 2023-11-01 2024-07-28 0000810136 country:KR 2025-05-05 2025-08-03 0000810136 country:KR 2024-04-29 2024-07-28 0000810136 country:KR 2023-11-01 2024-07-28 0000810136 country:US 2025-05-05 2025-08-03 0000810136 country:US 2024-04-29 2024-07-28 0000810136 country:US 2023-11-01 2024-07-28 0000810136 srt:EuropeMember 2025-05-05 2025-08-03 0000810136 srt:EuropeMember 2024-04-29 2024-07-28 0000810136 srt:EuropeMember 2023-11-01 2024-07-28 0000810136 plab:OtherMember 2025-05-05 2025-08-03 0000810136 plab:OtherMember 2024-04-29 2024-07-28 0000810136 plab:OtherMember 2024-11-01 2025-08-03 0000810136 plab:OtherMember 2023-11-01 2024-07-28 0000810136 us-gaap:TransferredOverTimeMember 2025-05-05 2025-08-03 0000810136 us-gaap:TransferredOverTimeMember 2024-04-29 2024-07-28 0000810136 us-gaap:TransferredOverTimeMember 2024-11-01 2025-08-03 0000810136 us-gaap:TransferredOverTimeMember 2023-11-01 2024-07-28 0000810136 us-gaap:TransferredAtPointInTimeMember 2025-05-05 2025-08-03 0000810136 us-gaap:TransferredAtPointInTimeMember 2024-04-29 2024-07-28 0000810136 us-gaap:TransferredAtPointInTimeMember 2024-11-01 2025-08-03 0000810136 us-gaap:TransferredAtPointInTimeMember 2023-11-01 2024-07-28 0000810136 plab:Two025EquityIncentiveCompensationPlanMember 2025-04-02 0000810136 srt:MinimumMember us-gaap:RestrictedStockMember 2024-11-01 2025-08-03 0000810136 srt:MaximumMember us-gaap:RestrictedStockMember 2024-11-01 2025-08-03 0000810136 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2024-11-01 2025-08-03 0000810136 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2024-11-01 2025-08-03 0000810136 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2024-11-01 2025-08-03 0000810136 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2024-11-01 2025-08-03 0000810136 us-gaap:EmployeeStockOptionMember 2024-11-01 2025-08-03 0000810136 us-gaap:CostOfSalesMember 2025-05-05 2025-08-03 0000810136 us-gaap:CostOfSalesMember 2024-04-29 2024-07-28 0000810136 us-gaap:CostOfSalesMember 2024-11-01 2025-08-03 0000810136 us-gaap:CostOfSalesMember 2023-11-01 2024-07-28 0000810136 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2025-05-05 2025-08-03 0000810136 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-04-29 2024-07-28 0000810136 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-11-01 2025-08-03 0000810136 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-11-01 2024-07-28 0000810136 us-gaap:ResearchAndDevelopmentExpenseMember 2025-05-05 2025-08-03 0000810136 us-gaap:ResearchAndDevelopmentExpenseMember 2024-04-29 2024-07-28 0000810136 us-gaap:ResearchAndDevelopmentExpenseMember 2024-11-01 2025-08-03 0000810136 us-gaap:ResearchAndDevelopmentExpenseMember 2023-11-01 2024-07-28 0000810136 us-gaap:RestrictedStockMember 2025-05-05 2025-08-03 0000810136 us-gaap:RestrictedStockMember 2024-04-29 2024-07-28 0000810136 us-gaap:RestrictedStockMember 2024-11-01 2025-08-03 0000810136 us-gaap:RestrictedStockMember 2023-11-01 2024-07-28 0000810136 us-gaap:RestrictedStockUnitsRSUMember 2025-05-05 2025-08-03 0000810136 us-gaap:RestrictedStockUnitsRSUMember 2024-04-29 2024-07-28 0000810136 us-gaap:RestrictedStockUnitsRSUMember 2024-11-01 2025-08-03 0000810136 us-gaap:RestrictedStockUnitsRSUMember 2023-11-01 2024-07-28 0000810136 us-gaap:EmployeeStockMember 2025-05-05 2025-08-03 0000810136 us-gaap:EmployeeStockMember 2024-04-29 2024-07-28 0000810136 us-gaap:EmployeeStockMember 2024-11-01 2025-08-03 0000810136 us-gaap:EmployeeStockMember 2023-11-01 2024-07-28 0000810136 us-gaap:RestrictedStockMember 2025-08-03 0000810136 us-gaap:RestrictedStockMember 2024-07-28 0000810136 us-gaap:RestrictedStockUnitsRSUMember 2025-08-03 0000810136 us-gaap:RestrictedStockUnitsRSUMember 2024-07-28 0000810136 us-gaap:EmployeeStockOptionMember 2025-05-05 2025-08-03 0000810136 us-gaap:EmployeeStockOptionMember 2024-04-29 2024-07-28 0000810136 us-gaap:EmployeeStockOptionMember 2023-11-01 2024-07-28 0000810136 us-gaap:EmployeeStockOptionMember 2025-08-03 0000810136 us-gaap:EmployeeStockOptionMember 2024-07-28 0000810136 us-gaap:StockCompensationPlanMember 2025-05-05 2025-08-03 0000810136 us-gaap:StockCompensationPlanMember 2024-04-29 2024-07-28 0000810136 us-gaap:StockCompensationPlanMember 2024-11-01 2025-08-03 0000810136 us-gaap:StockCompensationPlanMember 2023-11-01 2024-07-28 0000810136 us-gaap:AccumulatedTranslationAdjustmentMember 2025-05-04 0000810136 plab:AccumulatedOtherComprehensiveIncomeOtherMember 2025-05-04 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2025-05-05 2025-08-03 0000810136 plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember 2025-05-05 2025-08-03 0000810136 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2025-05-05 2025-08-03 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2025-05-05 2025-08-03 0000810136 plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember 2025-05-05 2025-08-03 0000810136 us-gaap:AociAttributableToNoncontrollingInterestMember 2025-05-05 2025-08-03 0000810136 us-gaap:AccumulatedTranslationAdjustmentMember 2025-08-03 0000810136 plab:AccumulatedOtherComprehensiveIncomeOtherMember 2025-08-03 0000810136 us-gaap:AccumulatedTranslationAdjustmentMember 2024-04-28 0000810136 plab:AccumulatedOtherComprehensiveIncomeOtherMember 2024-04-28 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-04-29 2024-07-28 0000810136 plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember 2024-04-29 2024-07-28 0000810136 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2024-04-29 2024-07-28 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2024-04-29 2024-07-28 0000810136 plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember 2024-04-29 2024-07-28 0000810136 us-gaap:AociAttributableToNoncontrollingInterestMember 2024-04-29 2024-07-28 0000810136 us-gaap:AccumulatedTranslationAdjustmentMember 2024-07-28 0000810136 plab:AccumulatedOtherComprehensiveIncomeOtherMember 2024-07-28 0000810136 us-gaap:AccumulatedTranslationAdjustmentMember 2024-10-31 0000810136 plab:AccumulatedOtherComprehensiveIncomeOtherMember 2024-10-31 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2024-11-01 2025-08-03 0000810136 plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember 2024-11-01 2025-08-03 0000810136 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2024-11-01 2025-08-03 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2024-11-01 2025-08-03 0000810136 plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember 2024-11-01 2025-08-03 0000810136 us-gaap:AociAttributableToNoncontrollingInterestMember 2024-11-01 2025-08-03 0000810136 us-gaap:AccumulatedTranslationAdjustmentMember 2023-10-31 0000810136 plab:AccumulatedOtherComprehensiveIncomeOtherMember 2023-10-31 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2023-11-01 2024-07-28 0000810136 plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember 2023-11-01 2024-07-28 0000810136 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2023-11-01 2024-07-28 0000810136 us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember 2023-11-01 2024-07-28 0000810136 plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember 2023-11-01 2024-07-28 0000810136 us-gaap:AociAttributableToNoncontrollingInterestMember 2023-11-01 2024-07-28 0000810136 plab:September2020AnnouncedProgramMember 2020-09-30 0000810136 plab:ShareRepurchaseProgramsMember 2020-09-16 2022-10-31 0000810136 plab:ShareRepurchaseProgramsMember 2024-04-29 2024-07-28 0000810136 plab:ShareRepurchaseProgramsMember 2023-11-01 2024-07-28 0000810136 plab:ShareRepurchaseProgramsMember 2024-07-31 0000810136 plab:ShareRepurchaseProgramsMember 2024-08-31 0000810136 plab:ShareRepurchaseProgramsMember 2025-05-05 2025-08-03 0000810136 plab:ShareRepurchaseProgramsMember 2024-11-01 2025-08-03 0000810136 plab:ShareRepurchaseProgramsMember 2025-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares plab:Facility xbrli:pure iso4217:CNY

Filing Compare · PHOTRONICS INC